Professional Documents
Culture Documents
图:奈特心脏病学彩色图谱 (中文版)
图:奈特心脏病学彩色图谱 (中文版)
Be DE END
Sie. CEA, KP a AE
‘HUE Pe Ya HIDE RAE Re. HE
SHIEK, SL HEMISE AE LAT HHH La HILL
A AB OC REE STAM). (ESE ELIA
AT HeAn TIA AUB, | AeA
MEH.
Fea EL MAT EARL AR
FURY REAR A. (ELAR A I A NY HE
ALS TESE PH BE BE DE BEET (IL
BITLREATT ). KML MEA AEE
(1A A LA a A 24
COMER AMAA ATT. SE SRS
fi ok 48 |v, — ae SRL OT FT
Re BF 2448 HL (LE AGE
TAIT UTE MATER. BONA MATT HE
ELBE TT, Sle DASE IN MAPRLAL 48 Ni
fA 2. 5h — IE 2 eA
FS AE A AoC VAS EE PY J AAT
PFs, DAT OMSL A. Se} eA
(INR2.0~3.0) fet £7 Co ME SE ARIF Wa, as NESE
HITE DRI. HRSG
NRT
180
MBAOB
Fel 19-2 AF NIE BE
SER PEM teats Fo NM He BHA EL,
Ig BeAr
in Sie * is
i, ABA ANE O DRO ER
ASD BA
CRT Ate nF
aie HeahEn aie
5 A BEET
- - a) BES z, 5)
MET DEA, RAO Sopa ropa me
RAE
181Re
Vitel
GOGH FS PAE AF Pa te HD
AR HG A LATA. BL, PE a ts
BCA PE BE BM FT Fe AG BEA a L2G ME SE
ee CoP. ELI CMe RH ol 2 RT
We EET. ER MESS EY
PROT WE RM. wR AIR AR AA AR, A
AAA WE. PERMA TIO MT HE
FRISCO.) Fe th eb te ART ZS
{AL BE FAL T° 1 at Ae A 200meg/d FL
Fs BU THB tH GEA Ee SEAS
J, OER Ue AL WE HE WL Ba Be a 0
I i 2 SA AT A A A GR
ARE AR USE — A A 28, SEE
SELF Fas A GE BSR ELH AY
RO. (RUE 2G PEE A A ART HL
ES QT HE, FAUT RITE LEE ARE
PARA. ZARA — MAE it A BRE
Ay 2, LR Fe 28 is BE 3
QT fa SOY HE A A AH EA A: Be
SE AIREY he i a PPA. Bh
JASE OT (ENR Hi — FA HB,
HLS BESS.
PANS RIAU A EO A, AN
SRE CTH A WE: SE PR AR Fs BL 2G
TAI, AA A B13 19 AE A OE
SRS HE AL At. AME ANS AS be BT
WG PEA LS ETS ITI AE. AEE
(OC FEL BSE AR BEL ASA A a ak BAL WWE AR AS
Bee VRS HENS HE AIS PT FE
RH Ha 32, SE rh J 1/3 AN BET
TERA ARO A LAER, Tih EL RAD T eke
PUMA TT AR AGAR Ba BOB LB.
SE BNE Dis WOE PM BASE
He AE TT OR Hb oR 2S Se ARC,
19-2 NH 19-3). (Me ATLA
QL, aSP i AL eT AY < TAS HR
ETS
VES AA Es EH Ob HES RATT LY
FRI AOA IT IE ASME LD SEs AS I
BREA MENLO RAD
(AR) BE FE ESE AI OM; BA Ss BE
TRAY, REUBEN, ER ALOR
FU 25H ill > ARIAT ( ULAR 19-4). BE
PRBEL FIT SUL ARLE, PD
BRAS MORSE, HEAT (Ee yk A BE
fil. EF PI AT
DEH, HURST A RR APE. TE,
Ail Fe BA TEES ABE ANGE EB
AES AG ASE BE HER ATH), AL, PRE
BAL a TF ORME. Bee AR TTT A
TEA AA HE OME EE DGD BL LE
4, VLE BSE ABEL HS Sh 25 SI
SSRI PGA bo) eR. FU ARE
PURSE BE (SPILL BLAME ) AY HH
(BEATS BL. (FED eB A A BLA
ACSEARLE i OL
FRU RS. Lae MA AT AE RE RE
EAE A ALE GES. PATEL YD
PERT MR AER AE ZA IT
AMAT.
sD MANET
TUBEAIT AE LES EY RE
PEDUREIAIT SET SP RE ARN BB OE
SATE IE SIRS. AEB. EER
ACSMEE DD Ss OCH Ls MEE Ze B23 BM A
Bei Ly MESS AA REIT BE
4 SEI Te] AS A BEE CE.
FEA NTE AS EI EE AL ME PEL
SMES AE A Sa LE Fe EB PR 3 J]
BoP LME(INR2.0~3.0), CDE SL Aa ARSE
FPDUNE ATT IEE 408). TE
RABE ONL ABD EAE
A ME. RE A A I THE EAR AS
RePetit
CELA I AERP WDA: ). CO AIESE ET
ASF Se AE ATER CRE, 2H Ba PT I
FIER RAR} FERS, PAD ME SE A A
BILE 4~6 Jal
TEASE LB fs BE EE
WE. VR A Be BL BE eH, pe aaa
IFAS GE AMY BBM, PA th a EVE AT HME TAIT
FiGh, FTEAR ES is OA, AAS BBA PEt
FEAEAR, [ALPERT 5 | REE, Bee EE
‘PAREN ALLY eA: i REE AE. Pk AE
UBS, FS TAURI ELUTE BA,
4 Be ATT WA BIAS FPF RE 45% ~B2%, FI
ML FS SE PRG ML HE BES AA
BEE RAEI 15 ia BEE RE
BATT «AERA ABA (BI HE Fs A) FT DC
RPTL MASH A PL DR SE HS,
oes Ie ASS FT LC DGG PHA
HRaa
HF |e i Bi LAG A Ud OL
SET A AAT — HR IN FE, DA HAG BE
HERSKA dt — THE.
MLE e
TU HE eS FE ZH 60H LAF AA
Abo PE IG OB HE EIS ICE
DRAR LS ERE TS RAE BT LEG FO
PECAN RM RH ALT AR
eo BENE IE, (SEIT Hs I SEA
4) OST He a BAR AE Be BASH FE IR,
BA LE AD MAE, tL ANG EE —
SIT MR. BIA EE TA
ig iA BRA Ti 2A a EA
AAP PAA OL ESAS BAG EL
AVE a CS OM a 1 FB
#2 AR FCONSTEV A RTA. SHE
SAR A A a FR te — PP BY EB
PALA, SRG aL FA RE SF Ce, CER
MB
4 EL UC, DADE
Nii» RSC Ds wi
FELD] Dt At 24 RAS BC, PA Be
DTA PRE ISATE MIE. HEP
Ase AB BA] DEAK ( 81~325 ) mg/d FF ABBA AT
PARSER Ls ULE a Se
RTE A IES, PT He
DB AA AFA at nd EPR. EWE LE 60~75
2% ZVI AR A LTA AAT DA
Ines Paes y BAD bs Bat
FRAMES ASAT TEAL
97 WH 19-2 19-3, 2% 19-4 BAH 19-3),
FRA ANSE A DASE MGA PAR
REP ARE AR BO Da Ts Le SE AB EEA
(ia) a te — 2a SABA ST RAIS» AT
ALP 5 HAE A ILA,
EE FAR AA 1 eT TI,
PEBHE DARI, PABA EME EIR AEE [ed
afi BE — Ae Be Bag 5 8 2 Ta 9, SFT)
NMG LI. PAE
SESE BEL EAL BA RO. SAE
LEE ASM, TEE TEA,
TS ASE BU BEIIT, FF AIEEE AT
Wife A RARE. Pdi PR PAG
AFR RS. ERI PI
DRS eS MEE ACA GE A
Wi). APATITE MATES EAT
BUTS MA a BELL DK LAL
SLID) 27 AR END bs A AS AMAT ANY.
SPA TIT YO ETRE HE A (LE:
Sie SELB ASE 9 SE BE TT Aa EA,
BAN A) 2 a) ELA | GE RB PE 8
(Bee IRS Be he ACE Se He RE TB
TPA LE. (KITS EES BE
SERB AWAIT OR. BA
FRSA EER ADEE, PRES
FrHE a Ah FATT FTL IE HS A ah TLE,
BREA TOME. REGRET
183Mah
#119-3 a Feb FATT
x 77 Bi > em
&
aR
mM -
we MED REAR
Sane Sh EA
smeRRteS
Sour eR
4
Re =
ARM ERBE- RBIS RXTE. ACR 0
ELISE LE Maho anee OP
(otal t| ‘pane
x
Oi
HEF AB ES
Re RET
HE FAREA TAR SHEA. AR
ENA BSS io] Bro — iS LE RN
WE. NAR Mh Re SS
DAE HG 7) OR OS
184 RABEA
SLIP As 1 AR A ME, EA BB
BEA th RH AE, RR OT
WD Fi BA TEE 25% VA Le, TUE 8 ETA
SAMI TEAR FS.
PEE VF ll
FEF mS) HE BE FE, ATO
SDP TEAS SEE LAR HS Aa LCA Ly
BLE EAT. LPL RL
MEHR. PAE SE AU Sha, AEB
AR BIE PFE BASE AEE AT 9 AS
FPA BAR LA. AG
Sa SPEER EBA, AFH RBS
UR, PBL HE HM BY ES LE
PFCATAIN RELA, WOR TEAR
RA Wb, WEA AT MM Tt Bh Ts EA
OS See A, SR RE A A HH
Fie AR UU FEAR Aas EHS a
AEH.
PEELED TEE
SUSE FE SE FEEL 225 aD Hy RS al
ANNES DSR A, TRB ES ea BEA ES
MET BORER. RUBLE A] BEAL IE HE
SEED PRY FT REPELS EG AISI, FT AE
PEA BY ce Fe MM A, FT ABE ZS 9 i
AARIESEERE. ESE LAL RB a, ol 28 FAS Hl
BRE AS DALY, A TA eG ah A
WAR, Fea ES th HE A AE IR,
PEMA EASE REA Hk A ET
FE IFW at A Bh, RE
THR. RMA MSR AD
eM.
FELTED I SEI
FE ML HE A> Fy SEEDS RAs NS a Ae RPA
15%~30%. Bs SHAT BCE ML HE Cy Ty BEM IB.
HF Lh AP A AG A
PHEBEE. (ED BEAL ROR ITE
Ke, A NH ETE AR AE os FEE A
PERI WEAR, LAREN ARTE Le as 1 LAH HR
MES SEED Aa ae. Pe te
CIBER A ALS LH HEL IV BRAG)
ErHE FB, SLA BABE 8 RD Fe EN HE
TORIES 5 TREE L Hy REN SIE ERIE AS
SEE AAEBER. [St ACES
PFE FE MAE Ly STEEN Es FER HET
TV, PAU we A FAS 2
9. Fe MLE Ls Hs EER AR A eT AD Ze:
ARR. SHINS MATT DM
ABU TE A mee SEI. BOREAL HE A
BEN Er HES WAM TC AK We 2G MEE SEE:
CARAS FPR
AOL ER EAS
BY 20% ~30% (1 AB ALE BEA Lo ME BR RE
ES ELE Fe AE Ds. oC EG SBR BEA
PA, Si 45% RA. BOSE
ESL Ly HOT RS a dn gH GT AE.
S06 Hb EU BE BE,
PMP, BRO. IIT RE
PAT, IA MR BRAT OT fe Be: EN
FRA HOG BELA LEE SE ROMER MA
LEA BMT NEAR BRE
ERC BA ERAS
CABG 75 6 22 tH SA GEMR, FBS eA AR
29 40%, SU BEA BK, A HE
AVFEDERTEL 2AE AMARA PEAY B SABE
RISE AS BoE DB. ATTRA B® SETA BL
FAD IY eS A 2
IEA ME EL TE IN, 2 BUREN
Bente USHER. ALAR, ANSE 5% AY AB
PLEATS 0K ABB.
RFA BL CABG ASP ETT BTA
FAS. RAL APS AS AT TM i +
APHID IK. ALT TARA LR AT BE ASME,
PTA. SURO FE GE aS, ATT
eR
185ED
TRAE BW BER AE AT AIT a, SE
PEL IAEAR ES ASRS
ARG 1
i WRIT HES FM A A. BH AN
ET BF BBY 2 TE PEE SE HB eA
(azimilide )J& FRB TORZG WD, HBT,
FAMED Oke. ARS MATTE EMRE, fn
SAS PRIN FD SSL ys ROL ( SE
FAI HE FR ESE EL ASAE ) BT
1 Pa F Be ; Ey BE Sh ARTE HK
A IRATE BEALL AT HEA, EARLE BITE
LATO ARSE LEED abs, PAB
LASSE LARA, ANAT EE
THAR AES OTE, AEB
Fey EE MUA. HP HMAC HE Me FAS I
AE BEKK, SEITE SOSA DET ME
ERA IRE — PAR AIS LA ADE
FF EL, PAM RA RE
BFP, (EL a i a HSS
BERENS MRT SEER.
BSI
Arial Fibrilation investigators. Risk factors for stroke and
‘efficacy of antithrombotic therapy in atrial fibrillation:
analysis of pooled data from five randomized controlled
tials, Arch Inter Med 1994;154:1449-1457.
Fitzpatrick AP, Kourouyan HD, Siu A, etal. Quality of ife and
outcomes after radiofrequency Hisbundle catheter abla-
tion and permanent pacemaker implantation: Impact of
treatment in paroxysmal and established alrial fibrillation.
‘Am Heart 1996;131:499-507,
Fuster V, Ryden LE, Asinger RW, et al ACC/AHA/ESC guide-
lines for the management of patients with atrial fibrilla-
tion: Executive summary. 4 report of the American Cok
lege of Cardiology/Ametican Heart Association Task
Force on Practice Guidelines and the European Society
of Cardiology Committee for Practice Guidelines and
Policy Conferences (Committee to develop guidelines
for the management of pationts with atrial fibrillation).
Developed in collaboration with the North American
Society of Pacing and Electrophysiology. Eur Heart J
2001;22:1852-1923.
Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initia
tion of atria ibrilation by ectopic beats originating in the
pulmonary veins. N Engl Med 1998;339:659-666.
Klein AL, Grimm RA, Murray RD, etal, for the Assessment of
Cardioversion Using Transesophageal Echocardiography
Investigators. Use of transesophageal echocardiography
to guide cardioversion in patients with arial fibrillation. Nv
Engl | Med 2001;344:1411-1420.
Kober L, Bloch Thomsen PE, Moller M, et al. Effect of
dofetilide in patients with recent myocardial infarction
and leftventricular dysfunction: A randomised tial
Lancet 2000;356:2052-2058.
‘Sheahan RG. Left atrial thrombus, transtent ischemic attack,
‘and atrial fibilation: Does left atrial thrombus predict?
Does absence protect? Am Heart | 2003;145:582-585.
‘Wyse DG, Waldo AL, DiMarco JP, etal, forthe Atrial Fibri-
lation Follow-up Investigation of Rhythm Management
(AFFIRM) Investigators. A comparison of rate control and
rhythm control in patients with atal fibrillation. IV Eng! J
Med 2002;347:1825-1833.
(Bea %)
186
RA5 2058
ete opwek
EUSA LIA VT WEAR Fs SHE QRS HAE, W QRS Bh ALis 2477 80% AL
BMANT, VIFRETHBES RES BMH, ZERMEKRA RBI CAD fos WAR se,
AOE, TAMAR AR RHA B] RAG RY AE 0 KH HS aE eo 5 VT 8
A, REREUMAARLS ERA SHE QRS 38, 2995%AXVT. VIKRAM AA,
BRM BARM AED MAAR RAM VT AGATE 20-1), VIA FRER
Foes ARE ESAS AIF Sik A HHS Fei TAH 20 FH 23 FP,
RANA
BL ALTE HE HL ANGE QRS >
Bayete FCS ERE QRS a ah Eo A EB
Wie te ELBE SVT) ait 5 BH JL
Pha IEG SR (Ae Se ah ta CB
SE) 5 SE ay oo ea CT TL
BH) HES A aha ee
BET FA LE. VTE SVT Ait et
SEG (0 SE ES SR PH ly PAR
BE. WS Te VTA
SVT, MRR EIR E HAL, VEST
F552. HEBD AT ML Wolff-Parkinson-White
ERATOR OL Lt A ase
SAow
VT UBT AGH PALE. AUR EB
PRR ECE A DEH AR VT. (EET OLI
Be IRAE 5% (WLAES BE). BRIE ZOE, BOT
HEL ORS WETE 465 HEF 12 SEL HL)
ABA VTAISVT. (IE, Hie AAA
ASF) IS SEN, FF EL UTEAR SH WK EA HEA
WAS AY 3S QRS BEL, BACHE AS LE VT, OR
ARPRBIIL ARATE. ASE READ EER
i VU BRAG Hy OAR ABE HE QRS 4b BE
BABE EAE VT. SVT ATARI VT, Bee
FORPERA ET ALINE. EBA
46 SF PAM FH FT HBL GE QRS AYSVT. [alRE,
2 UU Be BIE AT GT ABORS HIE.
TROPA RES VIEL, RIT AYR
DEFY EAT YTS)» PY BRA AR APS A A HE
QRS: Da HS LT SVT SHEE EH
HE MTASE VT. RIK A226 AT eb 9 9
QRS LAE S AVY, MAES Ait,
fe i REHEAT Ha A: A AEC EPS), LAE VT
SSVI MISH.
I RAL AIS
VT HIME AERTS AR,
AAG VT AYIA, Ze SS HM PRE LVEF) 4
Fe FAL. LEA TIE WAY, 5
BUBB VIM, WHE He Ze ty 2s BF uM SBE 10%
BANE AY VT REE. EL
DRG Ge Aa TEL a IR RT HSE
BE. VITALS | BE SE I ER
BRAS, BBL EER IE( SCD). HR HE BT
PARED RROD, BH RAIL
Fe, RUHR, BASRA PATE. AF
I, RPE VT AY SE EEE AE, BREA
ATL EAL, PAS Ae PT EE AT AE
VI AR He A.
BR
187Sema
F120-1 DEP eLeahy ic it
ROR Me Bi ye
SReH
is
EtiateerseRonas
Fae ADE. SHEET ER
\ BE
a
Be tbotsah 21k 31 AH 2} UR: WB de
MDMA FR ee Ale BR) S| eR
SORIA
RARER oma
DEAR
CoM RE OMNR HRS
BRS ALAR he SH fo HEI
soeaicnen JERE SESE RRa Ee
Ke
MRL wae
SPER AHMEM.
RRERAB ” &D
Ree
Cala PARED
188 DERESome
iOS MATT
AB ME HN TAG SE A HSH, EE VTS
$226 tL CBC. LH, fF Be 4D SE) RAR
PUL a> BIE iS DE EE
eh AGE A a CST. MAS A AR
FE; «AR Fe FA A I SF
MEIN M24 2 A 4 1 BB EAT PRD
VA AA. ET HSE EEA AT
AEA 25 (AOU RE, BEE
Dd PR ADB AT OE YL FE KS A
A) WN RAVGAS A te VT, AT Tad EC,
Sd DR eA RWC a ET AS
HE. [eA ELBE Ha SPF IL
Hh. BLES TAIT ELAR, PR} CALA IE, 244 TE
TS FESR TROL. dich FMI AIT IF
20) HAT EDA ( PA120-2, 28 20-1).
YURI baie
HOHE VTE WL, RIT PF
CREATE. EE LA RR
(ASTI AS Ta ( FA 20-3).
RE
CWE FET SAF BAT > UL EE
SRV, SOUL AST. OURO
FETE FEAR OWL, BAG EMERG VT
HH TREBR. 8 SOM VTR
AAG HK. IEE LAY VI He ite BEET AS
LAG A, RoE Or eT is
SEALER OL APA IE AE ML ES
EAH HE PER BH AECICD). ICD 4
BWRAER WT ET 8 BAL ei BE
LAR 2G. HRA TE HG EI
ASL ALLEY BSE ABLE LR TRAE
eM ALA DT DCR. RR TT RR
BARES EMGAGE VT AG BH
ALAM A), UCB RR BIE AR 5
hy, BS FE ET i 2 TH WT A
Hh, MEAT SOE. BIE DHEELS
RR RRA, WER eI RA A
AY NASER
PRL
SP SKALD LA (DCM) PT AE ACA EE.
BRINE A IEA RE. BCDC AS Fy Hf
FEAL WG HAR 5 INGE ACD, TFET HE Ae
DPT, PAY FEI AS AR EPS JOP. (HF
SYR Sb— A OL, BR SCT HE VT, 28
FRR FAM AIGA VT. HO TTIB LE VT
FE EAS GR MAS MDE HE BED EE IE A
HIV [ASB AYRES, 26 2 eM i fee I
SSIES, STH IE MITE. HT
PTAA HES OT fle HD VT 9 A, (LB
LAGS A ICD.
MZ, DOM A OILS IF VT RE )
FM 2 (RFS AT SE PAL EY B SEAR BELA A
ACEL. CLBEA ICD 4 (8 FH EPR MR HH AB.
Ai FEA LEE VEEL RR
DOM ASH ESE EDO, BES
TATE a Sa A OAL. RSE
ALR A Sik HY EAE BG ICA VAD REA 3B TE
WABTIEW
AES. AL
ESSE HSL a WL IS Ht ES A EBA
ICD. HT RRRA MATTEL ER EE,
SH FAL is RB
AYICD. RAT RBIRAA B SEARBLHI AIR ICD 2s
HS HAC LALO. 3 HI BR SAA
7 fee > ic.
BR
SRAM Ah MAA. WL
Sa 59 GW AEG
2h, TP BAS AK SE 5 TE
ASA TV RARE. SATIS Le HY
BRS
189Btoaie
a
Fel 20-2 SEA Le a ik HAE
igi ,
Wieser eee —
eta RRA MO
amix POPE peo fok
mae Rae aaa
Fae
CBRE) (8722) “
ate #01)
ate
‘CBC
[BARR ELE)
BUN, ALE
UG
RaAPSOR i
MRERT SH TH PERTEATHERSHAAL SH
(ARTES RIL ALAR TE ) DDDR. MERA RAR ATX
emia FER TH MR Oe AY
hy
2
go ge
soevennent
Bis stemenes ARMS
A
REE ECCR TERM EEAAA
190 RRBEomae
20-1 Ritdetwm— Hak
- i fF
caD RGR. ICD. BB. ACEI. +RFA
pew RPA, BB, ACEI
HOM 1c, BB
me ICD, BB
ARVD ICD. BB. = RFA
RVOT. EW MEF RPA SERIE
HARE REA MELA
ARRSeHEHE Da = CAD, EF>40% tHe HE. BB. ACET
CAD, EF>35%<40% HCE, EPS ALEVE A ICD, BB, ACEL
CAD, EF<35% IL HCH. ICD. BB. ACEL
DEM>35% BB. ACEI
DEM ease ICD. BR. ACEI
HOM EPS+1CD, BB
Ca EPS#ICD, BB
ARYD EPS ICD, BB
TEAC Bes LRIML BBL REA
setess te bah atilt cap LE. BB. ACEI. £1CD
(EF <35% ) Fe
Dem TCD, BB. ACEI. JE2fi thi
HEM. ICD, BB esi
a ICD. BB WBA
ARVD ICD. BB (eRAIEL
JER OME PehASALBeiL. ICD. BB
Kore TCD iAeH. BB
atest A Ea CAD, iit ith HEE WE, BB. ACEI
CAD, Lah AEA ELE GTEC
YET CAD Miz. BB, ACEI, RFA
Dem BB, ACEI. RFA
HCM BB. EPS+ICD, RFA
BR BB, EPS ICD, RFA
ARVD BB, EPS=ICD, RFA
iE Co BB, RFA
ACEI: hv 9% 40 WHOA ARVD: Sk CRI A a He FAS BL ABB: B SEYLER {CAD: EARS BROAN DCM: 24
20.C WLW EF: Sb HES: LE te HICM: RE LC LE TCD: PRE REA DBO ARV OT: 18
Hutt
RR 191Some
BRL VRER 4 Al A Y
D. SHPRR ft
OI SRT he
ie sleek = ina
‘23 RBBB AONE HE VT(BERVT) SPELEEE HOMIE VT
¥; es 1
Ht ; pie | +4
I |
RERTEOE eREF ASTI
SRLATIBLE VT
ig My
BRE KRID
eee, #
77 LBBB BLY A
RERFADE
SetEVT OTmBER OT aR
Horst w. A
BAP RDL EE fy
B. FRH
ROHRIEA v
eRe A V
OTM ERN SUM VTH OTMMEKT SILI
EMA RATERCMEM Rk HSB. FSRTERRD
RAPT RE REE
NEHA ECR
ee
a. BHF OMA
ESeRieteR
AIOE MTSE
RAAT
PVCS ERR. ae
Tate FRAG
RR:
eGaeuesae
WEEMS
192 RRBbw
VIREO B SEARLE ALICD 197.
RRA EAD ERED
BURA MEAD BARA L(ARVD),
WEB RE HEAT Wi. Bal
Be EB Dy MATE UTC. UES
BEACH OL ae
DRS. HEE T He Ac EE
AR. ARVD Ab ae (60k ib PERE. HEHE,
FUNC B AG NREL BT ARVD RHEL. Ht
PRU REAR EAE FEB. ARV FS | Beaty
CE IRA —. ARVD |i
VIS BEREA ICD, ORME B SEALER
FHSAA 2.
He Ta 0 EE RA, PAE ICD Ae,
SPT Fa OD A S| RT AE,
AAR LL SEFL, ABE oh Fn ES TT
5 A FY AR A PL A EA. I Bs
VE ASA AT LA REA AIT.
ASKHESHODR
ABH HIER Daa — AT ie
DERLAM, BR TPE IE
FORA. Lott PEG AR ACH CAE SEE
Felt IE AG. Ee ALA AT AEE A
ES IN fa Je OL. 8 HAE HAL VP
EYAL B SE AREEL AIA BCR, tid Je Bio ESCA
FRAC VT. Ar EHC VT ABA S|
EE, ALT PAI. WER
BAB VT RE, PT AEA T HAE A eA
SEIT. PERL AE BE REAE Ha 9 BER SE
ERA BA (HF OAL, WA] VTE
LAER.
SREAS SEL DR
TRUE SHEL
SEBO, MEZA HI IE
Fev. RM HETE MENLO KAT Ze IE VT.
PEGE AAT HEE BL RM fl.
SPIES RCH ASE Ae EL BR HE LE AEP TB]
Bb. PR MME PE, HE WL — RR A A
PEA A A 9 Be OL HT fA ih BT,
GORA AAT HEAR, PREG TAIT hi AT He
ALBUS Ze AU BU MATT, Ade
FRCL AUREL.
TREE baat
AESPSEHE VT TEASE 3~30 BEAN VT. 4728
SRT HT FOREAR, 47 Se AB BAPE SEUE VT HT 9 ibe
MLB APEC. VIREO TE OF EBL
SME ARG SE EDIE RAEI. ARES
VP AY TIT ESAT RATA, IESEHE VT AT 9]
AB LDR HEF, FAAS AE 28.
CAD JEAEAE SRE VT AR HY, IEP
ALE SHAE A Ae AAG BE WL Ls IC.
3797 HUE LVEF. LVER AF 40% #91 iF
B ZAR SILAS SH) Al ACEI2K 254%). LVEF “)-F
40%, LAK F 30% $F Wit 4 WEFT LAE RE Ae,
RATT, WNL AICD. Gat HELL
FB AE ES AH B SEALE FA AI ACEL2S
254. LVEF Ay F 35% # IL 4 BEA ICD, [aE
(EFA B SSS BALA Al ACEI S254 OW TT
(OLS 12 38 USE 17H), DERE HE VT MEL
A SE C0 BF
A OAL(DCM), LVEF IF 35%,
PERE SEE VT 14 BA ICD, fH B ZAABHL
HALAL ACEI 625%]. HF LVEFAF-35 %
AY DOM BA, aE PEO AR AY
AMBER. ZBL BOER EES Set VT EB
TUT BEBE.
AEE A LG SA BC AR HH
EERAA BA HAGE VT EER. UE
FF EPS HOHE, WIR AGE AEE VT, 180
AICD. FERAL ER ARIEL
IVA LE BEA ICD, [ADE I 4 A BSS BL
FLA (Bk) eB.
SE PAAR RP SEE VT, FG Bi CES ES,
De Bt ts WLR AL Ae AES Oy BEAR A
RR
193Bom
a a
FACIE BEAL NTA TT. RR A
EAR, HUI Ze PEND LE, TLREH
SPST ITAA TT.
S)etkate bahia
SNM VT AGE BE ETE A 2,
he SAH t AMG ATS RATE HE VT, Wie BD
OSC URL. UTEP IR HL. AEN
Be AS WB A TE BOA HH, ALO
Weare PSM. ots Linas EE a,
BSAA ACEI RY. WR
STEE VT Bet MS EA ICD 35S FH
Raia.
PHL WG EIR AY WLI. BE
BRB L AR HEAT SRA BLT IE VT, BG
Fe WG, FRU LAR AS 2, HE EA
TCD, BABES B 32 PARBELANP SR), 4 5 Et
ea
CES TEMS, AEE LR ML ATE,
ANS Hs LS TE VT FI Ao FL,
BRIM QTR EE. SH VTE — BAA
PET, fice ULF QT aE a, FGF Ot
SAR AVA LE AY 51 QT MIRE HO,
ie Tag Ta a A AY ke QT
FE AUZG OD. Ib, FL EEE RIE
SGI ASH YET OE A AE, NAG EAN
Icb.
Imad se YEE AR
JSR HES HE A ELS FRAT) 9 38 BL
$6 HE S0~120 HK / Sb Z Ml]. ALVA WL
‘leas LAB ETE TAIT fe EL hl
Sr AY A AEM. PRES
HOSEA RAE SE. AIVR RUS AF, 20
WRT. WSR AIVR | BME EAL, AT
RMS A. INSET LAY
WITT HE STAR ATV, PSHE AY EP BFE
Sha RMIT. AIVR IPB SR
BER AER.
SBA
SEMI HTA( PVC) A Fos AR, APSE AE
AT LE. AB Ae Al RATE PVC 8
fEJE HERS. (2, PVC Be Be AE aE
AY PVC, FTI Hed WEBER AR, lineal
FP FOL ED LAE GR
LI TEER II BL BR HE PEAT
BRA. AERA IER, LDL
BUD: GEG eA THE, HIRT A) PVC TT AE Fe EE
BETA RAINE A Ls
FERS AT AA aE TRL 9 A
Wi). AR ALOR RPG Bh AA AN EE
SAA FRE PVC. AER
FRLEOUH B SER MLMHA. MEF PVC ARR
HE (AF 2-30 SP), HERS AF A LE
TART. (HL, A EAR PA AY
PVC IN REDETT RIM, FA, 3X A —
fea
ARG
BBG VTE — AE AR a.
SEA TR (ERI AR IS RTT SEL LAE
HBT wh A> ACG BAST RC. 09 RE
EARL VT GSE ACA BEE 9 LE HE
WU THELEN Rote. Tike thei aT fie Jk eee
fr TM TL, AEB OT AS LEAN
REPUTE. FARRER ANDERE BE
VT ARORA Oh, PA “AY” Co ULAR
IRTP AE BOL A AEA. Sil, Bit
AEA AT DE BERG AAT BE AT EB
BURR ATT PARENT
BAM
The Antiarrhythmics versus. Implantable Defibrillators
(AVID) Investigators. A comparison of antiarthythmic
‘deug therapy with implantable defibrillators in patients
resuscitated from nearfatal ventricular arrhythmias. N
Engl | Med 1997;337:1576-1583.
Bardy G. Sudden cardiac death in Heart Failure Tial (SCD-
——
194
BRBeeb eaie
HeF?. Late Breaking Clinical Trials, American College of
Cardiology 2004.
Boutitie F Boissel }P, Connolly Sj et al, and the EMIAT and
CAMIAT Investigators. Amiodarone Interaction with Be
blockers: Analysis of the merged EMIAT (European
‘Myocardial Infarct Amiodarone Trial) and CAMIAT (Cana:
dian Amiodarone Myocardial Infarction Trial) databases.
Girculation 1999;99:2268-2275,
Buxton AE, Lee KL, Fisher JD, et al. A randomized study of
the prevention of sudden death in patients with coronary
artery disease. Multicenter Unsustained Tachycardia Til
Investizators. N Eng! / Med 1999;341:1882-1890,
Maron BJ, Shen WE, Link MS, etal. Efieacy of implantable
cardioverterlefibrillators for the prevention of sudden
death in patients with hypertrophic cardiomyopathy. N’
Engl | Med 2000;342:365-373,
‘Moss Al, Hall W), Cannom DS, et al, for the Multicenter
‘Automatic Defibrillator Implantation Trial Investigators.
Improved survival with an implanted defibrillator in
patients with coronary disease at high risk for ventricular
arrhythmia, N Eng! | Med 1996;335:1933-1940.
‘Moss A), Zareba W, Hall WI, ct al. Prophylactic implantation of
1 defibrilaior in patients with myocardial infarction and
reduced ejection fraction. N Engl | Med 2002;346:877-663.
(Eax B)
BRR
19521H
PBA LS
ERBRORRLAA OMAK /T, SF 60K/ PHA GMA, ik eH S te
RAGE SE TAL F OOK/D. REL GRC Hh HAS PME TI 50k / PFE
KA th FR aR Rap eG MAR, BR Aap EEK AH Hho 21-1),
HAGEL, Gb aah a EI
FERMENT. MERMEN Lahtt
Ty MAE RA RGAE HE. BLE
AL REG | LAYS GEAR AR LEG
RARITIES AE ROU. Mt
WIA, HY A BEF BN TB, BEE
PEPE MLE Hy BE, BLEEK PMP RA ML
LARTER an.
RANA
CWE AES ABE FEA RB) TG «BE
Bi BEANE BRK MAH. YG
SDAA BEDRMS, DES ite Saket (FP
FED AG AA EH IM RC NYY |
FLEE. BEGAN GG EEA DALIT SOR AL
BERANE LE SEC, BE HLS wR BE TR
Ai RABE AEM, TT FRO. UGE
Meat, HA ZCRR ANE TR ASH, SESH AE
BA, Fis 2A 1G SEN. BERR eS He
FASS IEEE SUF AE ABD ASB ER Ay ED
Fe ZAMAN EE AE rH BR. ANT A
ASAP ETS He RIV 2 iy 10 FD A
ABER AS Fe 7 344 He BE A,
SORE Mt. ASAD a LAER, UU
TCO. HE DR HIE . F304 Sah Dk See ATS
PREMERA » BELEN IR RR ET A A HE
ARE, SB She Hy SH IR SEY HT
1 Cot 288 (4 IEE Hb)
FAGOTTO. HRY
INS AA 8 GE GE ZS NY RE,
FEUER. B SEAMLMT ARIAT LL
SL A 2H EPL HEED,
(PLY ES J ak EM BSR
DSN TEA. Beta aE e naa fer
‘ic LHR MSE 2A AERA. Lett
BEB RA AS A IR 7
AL BLM. RATAN AT BH GE AY B SEAL
HEFL, CRT Ay BS PALA BS
PRASBLAEH. Sb LOA Cea Ew
(SSE D5 As A at Se A AO, (EL
TERS EO PEAENG SES HE 19 AT SE
FAtHE, FESS INTHE SCHUM AT.
FARCE RSET ACR
Ra ie AR i APA ke A A
BE ) UA BARES EERE ( Ty Be EA
FEF).
SAO
SBE
BB NREA Bk Hs BB ARATE”
FE WLAN ACB EE CA, J A AA HY
SUTIN. SERA NH TT LAR SP
TAL, HEROES oi AE ESI 5 UT ARE
PRL me, 1 ik aR ew EE REA
PNGB. SE GERAD NREL IR ok AMY
SHEO BAR. AE MSE La. KE
BUSA ek A 28 Pe aig Se He
A Bhi KE HE HG CE A SA Be AB GAS
es
196
BABARWON A
el 21-1
HE). Se AL il D4 SE Baz SH AA BA,
AISEGASA NE FHILM. SEER MLA,
SEE EAT TAR AR ETE, (EL Bp oh Pe Be
(TiS HERE RO MiP. BLL ARO,
FER Sh — PAE PRE, DI PRY SPR ASE
HARIRI APL. FS
Sar ABR BEA PA —4P P Be.
VASE EOE PCE SP EAT a, ESE
BSE ESE EAE SF ILA 8, Al PS
‘WS EYTE PEE SF HEI21-2).
Behe SOLE
EB eS LB SEAS PR (i) 3) SE HE
KR, AF 200ms. HY Wn A. (IE A BTE
BBL”, SATs BRM AT BLE fleas =
(121-3). SPE 5 1 SH A,
45: 25 i nm AV Sie TAN leh SE TY
PARE RE AS ELA, EAE A
TEE AG SLM 1 — BE BE FEL
SHARE BOL, OTA DEG
Fat, OOS — I Bs 1G SH PO A BEN,
EAS A/T. BIRTH EASTER HOR HEL AE XE 60~100 %/4}. (BIE M AN
MEF 60A/ 5h. IBA Pan ASMA te I IN oT LUA RULE. EE
RR, THE SORREE 40 RK/. RHA M—F 23 HAL
FEA Sait LM Bee SEP HA 6 BELA BY FE
E> Scan OA, PB — EB Be 1 BEL
Hi FBGA i FE DALE TT BUR AR AE
PRIA 9 9 fe HEA, (CFE, AE
CIE MEM, PART to Bit Bs IIE SY
Feld HESS Ray HR i at RD So AE
BEIM.
Ie EAE SF EL HY BL fe YTD
Wi, LP HG TA) ATT
(PB 21-3). SEEG LLANE, PR I
EME, A+ PUAE Pies,
BU. ROMMEL AS BLP 2 4E HED
Hak MA IY OT AE te — eA oh. BEER TL I
SAR BR mR IE” BLK, PR LAI, ERE
AEM ATH EL F, FEHR HH BL P BE QRS BEND
Wee. Dk ADL BR AR ar BOR - HS BAAR
SESE, SALE HEAP AULA.
DRA} PARLE Ws HC BE TAL Wy — 1 TD AL as
fe BEL AE DER EEE i 8 1 SLA
T RUA, BE 1 ee BL
PAY HT ALO, AREA.
—_—_—_
RRS
197RRR
Fl 21-2 8 bE
a SH
ORs 382 [a
Ls 60~1002K/4>
B. Bt hits
PRT EH,
2 RBS
C. Rit mite
PHERT RRS,
RR
poh ss
e ee
oentoR
Fete
BBR
ADERPD
BAA ABA
PBA. PA
(a8). Pr pasa.
AR MS 3
198 RRSRMR
FA 21-3 WAG FISEE
lee esi i
PRIA RE Ae
SPR TPR! Pape toto pa
}0.26 sec if 0.26 seo ft! 0.26 sec'iff=#1 0,26 sec'll! 10.26 sec
ENP RISE #8 ORS IR, (BPR IAI MAREK , 30.2 8)(>5-T 4)
PR SABE SRE AC, (6) a OTS
DRM BR | CLR)
YYW
BUAVARE ff SRAR: eSH-HR near ORS: AV EESTI AER
REFIVTES PR PRIMRTELE 46; PR DAE
—bEK
PR ie MRS
(PALER ER
2H PRIDMATEK, QRS RRB
USPS BOG UL AES GRY)
PREMIER SRR ORS 3. 2 8
SCA PR ia) re
BRR 199RRMA R
BAe MRT Hs 8d, A mT
PLE PUA Re SI, RS ESO
5 SEs 3 BEL YL Pe Te TT YB
i, FEAT ERR 64 ELH AEB BEL
HUI Hy BL 1) OR A, GL ET
FAA EBAMY RE RNESTG Ha HG MT
HEEB, HF AM 90% (ABE EAA
BEAMS FA REAR WR, aL as 8 2 8
REAL. SBE, Aish iki
ORI He 5 EAE BE, PAAR A Be He
WEE, WR ACE, TE. HR
UAE eh FS HE a — TD
AEB ME. HIRE CL WLREAC HEIR BY 56 ek
VBL 4 eA RE, EL Sa A HEB
“Ge At ai ABE Fe EIT,
WS BR Se SAM, oh Fee AE TH I
21-4). PeaeLt AT LG TS, PP. RR
TELL, (EPR fa OASIS AE. ALR ELM
CALF MENA, QRSUEA LSE RAY
BEI. MLA AOP te 24,
EAE IRAE, IRE HS He 40~55 1K FP,
FE RIE SEER LE TK TS ORT
GA A WL AE. ARB
(ite EAA, PAARL TE A LL
FHA SW 48 TB iE 29 I) F 40 Ye > AHL
$8, Ai RBH LE YEP
Ge Beals WEBEL TT VA Se FE BT UH A J
PRPER. FEAR HEL WEBEL PT REM EL)
ANDERE ASEH AE EAA LP BEL, BIC:
AE TH JL RES EH EAE AB BR
SE RAE BLL 9 RL = 25
He) CLARET REE (UTE BHA ARE
RUIOG LES) EAR R E ( ASRR .
ee He a HEHE DS Le ) A LS CL,
BRAR).
BNE LRT
Bie HE LA Ee I
LESY SPADE TA ARE HH PSS PR A DE GE
MT HS, FBS,
MEIN), MOAR SEE LR SEE EMER
SEMIN. ZOMG SERS F Be, tH BIR BL
EHSL EF IMA, CCAS FMEA SOmmE
WANA RODS. MAME TB
SDK, SF ARS. MEE
LB ASE GH HFT SAI HEAR KH),
TTR FCA bt ae AF 3
BSE PPG EAE 6 9, (ELH BEES BE HE:
PEATE 3 Bb) SEM. MAE TIA, RIG
i Pay LA ALL AT LA KS PA
RL CTI Ae A. Pao HW a TL,
5° A] CAE A FA, EL
ARTA. PRR TTT LA RNIN, APE BR
GH ERA, SP BOE ETC HK
Habel RAT A ENS CE BL
RRSEAR ATIVE SU LIAM. BESEME
HEA ROH ETE ASC NBT HEIR BE, SF
BSR MLR ALEK
BRT
eB Ha A HE YF
Fee, ATTA PEE Be RR a. E
OAL Sah 12 EKO PAB] fa HET.
2G YE TEDW AL Re HE HE, (EAS EE
FEBS MEARAB ZI DET I EE
Holter He WI BEE BI SEHR, 24~48 HT AY
WW. eta AT RE Ae PIC He PEL
RAG BR, RTT ESE AL. RE PHEAR
BAAR RAE R DEAT 30 SE A Mea
SF RAB AR Be EA Re PEAT Be He
BPALA KAY Loop it at i, Mec iM ETA] FY Es 18
ANS]. We RAR ACI TEREAR A HEY, FT
PALA TIOR.
RYE FS RH YC LP
BORE, [AA SE EAD EAS BA ESI
PERLE A BEA. — MAH ATHOLZE,
SEE SEAM, P? QRS 32: 1( 78 21-5).
200
ReBME
Pel21-4 BeBe HIRE
PIRS ORS ZAK: ORS RIABSF P hse
ML (2)
SRR
a
Lanes
aaae cea \ “i a
Rota x z a
RELR) om. cseane. RRR FARE.
Hebe 40-50 R/3) UE.
9
2 mano gf
BaP).
mmm \Y
Ean OOH
Ree) “ae ~ Hs
ORDEAL. ORS ROURRE BARALIE,
me 20~40R/ A EEA RE
ARRAN
ORS BS
LR FAB 20~40 KH} ) BE
EGR SiG
ae
Sars wR
ERE HTT (40~55 1/5) )
aE BOM RRMBE NAR.
SE HABER ZAR emia ate
ade SRERHE HAE
Pee NAL SR ERR sews WNC Be
PBSORS RZ AAA: ORS RAS RF P KAR
RED
zEHH
PRR
ii i
PRS ORSRAK, BART ORS
4
}" SauNbeRs
RS LE
FARM LR
DEBS
—_—__ OO
RR 201RAVER
FEES PAGER, FERIA PR EAE 1 AUREL, HER ADORE OTE
WERK. RAMA REM oGR L i PIT fe PARA, HOTA FA OTHE Ah MN nT ae. Ae
FE BEER LA fee MY. BAS AN i ELSE TL A as Ae SP BEL A (A 49 BUS)
BR, SOLS: | RO AS SLL MAT LAI. = (F216).
Pel 21-5 Bs 8 BL Me
Sm — PRT e—TORSR. epcree er ee (BARAERAB
ATRIAL BMPR) . AML. ARERR | ae AY. AAEM EA
SEP SE LARA RR ARORA. SOR UR LiA ASE mE HIRE FS
FA21-6 SEEMS 98 5 LA
prize 4 see
Roth x
8
BSERRR RE
RSSRRERA WO
eae
a8
BRI j \ \
RS Tel BE
Bele alee Neo EE
19m ° P
P Pe P
Ae
Sruxners
202 ERBRM MER
HLS PRL He AVE BRIA Ds BALE. —
FRESE: BLA FETE BRA, Ps BTA A aS
AeA}. = NESE BELLE SSE PER Ao Ba E
Bie WES Fa BEL SBA SEEM. HE
Fett FIAT ALANA HEAR aE. — BE
AUS PS RELSGA, PP Vials aR Ma AL, OH,
SEE HH, Se He APH ia) ly FAs P fa 8 9
PR. BE TT Se eB MIM, Se ee AME Ag a}
i EMBL, BE PAP a] IO EL PP TIL
‘PRK.
SER OMELET, PB QRS UTE INS
FAY. DEE AP OIE AR SAL ss LM, PA SP
(ake AT ELA HOOK AL TE HS
SHAT. PALM, ABE > BN IE
at, RHE EH, OE BA
FPR HH, ML EM ES.
DFE DBAS Mh UE ESA MO EAI,
ARETE LS. 4SE HEM HH A Peat
aban, Sete MSN Mea A Bs, HLS, HE
AE CED SOL. At, LPR AEE
FA HET We se Fee EBL.
FEY iS WI He 22 HPLC.
DWE LEED, AE AY Dr TEAS AF
FALE CMe AD aE Ae. APSR HE
Seb SEE DRA Th EE,
Hi BBR te AEA SE EOIN, SURAT HL
SIRE RN ASO. Pati Pose
TOFD A AE I OG REGIE TH AE ee,
LAAT HT 2A FL RL A
AELAL Pty ES #8 TE Hs EH, BE ALA.
IG Te a Aa SE eI, 3 A
ERE THEA. BAI He RR HG,
PSHE A AE, EAT a as MU i
A tH.
EB SiaT
AAR DEMS, ERATE LE
0. SURE GIN, SUIT BA
NI KET LAS OT GEA. MEP
DEAE LST ASM AE BL A HB
HAM EMG. TENOR, PAE
WR A, (EL PEA A LL
SOREL AMIEL, mAb HE. AR
DHT it HAP SE SEI ME AS BL A
ASAP RCHEAT IR, 34 ELAS RCE, Bilt) TE
Fil, AGERE AE AIHA AB TE 2 CE OB 26 Be HE
TB. BR, aN FRE CLE, OT HEA
Bi MEAS SC AGALA AIRE.
BALEARES LNAI TS AC
She TF BIRRIECEM AK AMAT HUTT RAE
BEA VE D, CLARE Me 9 EFL Bk oe TT
PREGA. BEARDS FHT
BO2501, PUD ERE I SERRA, IR
Fei 2 FEMALE ERAT NH
APT AHS KA BM EAB, FT
ik FE FEAR AAG UL. ae PELE 1 5-38 £8,
AC ANCA sl AU AT WA Bede — 5 A, AE
BL es AHA.
RRA
AUREAR ATL BB AIT — EE
HOES Ae 8 La ER AE PE REAR AY BL.
BAY Ash ARH, (SEN A A EA
AREARAEAR 76 FA. Hh, ALE AE PE
SUEAT OC BR 5 ET BE OHA, HEE ETO
SRB SP Ta] A ES 26 EEN SN. le
ADMIN AIRED) JS 2a IE A LTE EE
RZ.
BAIR
Devinsky O. Bradyeardia and asystole indiced by partial
seizures: A case report and literature review. Neurology
1997;48:1712-1714,
Gregoratos G, Abrams J, Epstein AE, etal, ACC/AHA/NASPE
2002 guideline update for implantation of cardiac pace-
‘makers and antiarchythmia devices: Summary article. A.
report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines
(ACC/AHA/NASPE Committee to Update the 1998 Pace.
—_—_
RR
203REM S
‘maker Guidelines). Circulation 2002;106:2145-2161.
Gregoratos G, Cheitiin MD, Conill A, etal. ACC/AHA guide-
lines for implantation of cardiac pacemakers and antiae-
thythmia devices: A report of the American College of
Cardiology/American Heart Association Task Force on
Practice Guidelines (Committee on Pacemaker Implanta-
tion). Am Coll Cardiol 1998;31:1175=1209,
Kaushik V. Bradyarrhythmias, temporary and permanent
ppacing. Crit Care Med 2000;28:121-128.
Krahn AD. Use of an extended monitoring strategy in
patients with problematic syncope, Circulation 1999;
99:406-410.
Mymin D. The natural history of primary firstdlegree atri-
ventricular heart block. Engl J Med 1986;31!
1183-1187,
Oakley D. General cardiology: The athlete's heart. Heart
2001;86:722-726.
Sheldon R. Pacing to prevent vasovagal syncope. Cardiol
lin 2000;8:81-9.
(Bi He HF)
204822%
DDR PEE BK
ERLLARRMLA MP AERRA MAMKARA, TAGAEL, ERRE GA
BP EAH 3%, EEE AH 196~-6%, 1/3 BARR DIE RMR RSE EE BT
HEEAA ARBRE BARES,
SWRI SN 328 OE AE
TE ARINY. RUSE, 75% -85% HER
GIB RLLGHENY. FBO PRAY Co ML BLA fa,
48, PSI EIG LF yaa SPB ER AL A
BLT. A AUIS
FIA MMTEIE FAB TE BOA
PDR. LH FUT 8~10 8, a HE AT SPC
DRE EAR APE IE gL A A
FAL Be it Ls RE GF PE
PAA. WEB RAEI, IM BU UE
FTTEAE, Fi AMOR Be bP HES EAR
BRB IRE Sh.
Wi RACER
BABI SEAR HT Hy 12 AR PE TEE Fs
HMO LURE HY AEE As SE RE AT
FH ME HEP EA 5 LAE
SAVANE BARE AN TT RETETEL RARE HR
Te Ae PERNT OTA A SAR, 829-1
BEN HBO) AF SE DR A SA AN BT
MN RAT BBG AT ERI, BEG
SEATS AS EWE BR GEM IMEI, FE
PREIS VM iS HE A BE.
EI BY ABR AEE A Et I SE
FGPG, LA: BE LH RR.
TBH. MEE WE A REE A
Wi, 49 5% VA: EAR BAR AHR SB ID
Hie.
—_—_
ERE
R221 RKBARLICER
+ SRAM AM EES
ish
etic
ie
ae
wa
+ Reset eaata
+ RUN
wisi
SEMI 8
PALA
a
wit
FRCS SR UC AR AR AH
‘A RA ty A A
IA eR IN
+ Ro
+ Set
OAT
HEMI ae
MG
“wk
+ Sat
AEN, eR a
= AT LMA
+ serene
SUPER DI TT
a - Pr
eteekotia
SR ASHER RO) JA FL LHL
SAF ik A TO AE 3905
AY)
+ Bick
205RE RR
+ RAP SBE
itt
ek
Atti
“Un
Hee
+ RAIMA
Bahioe
EVR A RSA AL
1 OR 998 J YB
BAT LFS 1A Ae BN He PE
JTC AEE. PAT SRR ea
2 BE 4 SE RSA eS te
HE in Oe UL : a RR SE
ERR AS EEC PEA MILT. SAR te AY
SA FGH LTE A, AAG BEA AE SR
Se 8) Se A EAR AT BD PE
Ble
PEATE ROR NE HAGE — Ab, 36.4
TR A RE 1 TEL eo RE TE De EN
g EN, REPE RE AM EE BS : BOR
DELP AER ASE: PR (ads HE
BH Sea AEB AI. WRW RATE QTE
4riE. Brugada 86-4 fie. Ae 8 NIA Ha HE
HC LAG AT BB) A EE BE PEARL
BEE. Mie. RD SS TAGE FL
EL
KBE AE WT Ls Fe PSE a 12 AL
FEL ACA Ph BAER ASL, oC PUL
EX.
sie
5 E09 A 4
8 AE) AEC LRG TPZ EC HS
9%) RES Be RRL AT IB A ATK
3. TEM Me LIRR AEE EM.
SELENE
AUR A 8 EB FE FB,
BOLT PEO. ATI Bae eee,
SOLA HEB FT REDE, ee ERY.
kobe
Pe Ace LI, LAR HAF
GRIN HE Ai Le SDN AS He Ls EI IGE Ls
SILER. Ba SALI Mot
BORE. ARK, LAY EAE 1
FEB EL BT LS 20 BE SIT, PRA AT
TEDEDR SP BASIT. BAW ah PAL ay Ze BE
FRE A TE, (AR RONEN,
STRICT
FLICRAS
ELST AEH ATH LATE RAS
(RATED. PRES, eT Sl
RACE MR RAR AS, TAG AG LF. AGG RL
ALR. REA » FEA ER
SATE HET TT Bk eG eI HES. ABLE A
ARIF HAR OR A ML, Eh, ENB aR
Pi CH 1 BEES TALES PS AEE, AO
PETE, RRA BS EA EE. JS
EAL, AL RHO HY I DL aR
BNR BORER RA AKA ATR
APREDEAE. ALC NCA RUHL A TA HAL
OE, REDE UERS. Fob R UA
BATH MIM. ELE LT EE ERK
AS NTUR Re.
Holter Kili
Holter Hc 89 Fl BOE T fii FEHR AS
RAI. 24 Arita 48 vibt ft) Holter Hei)
REF 1 PARK EE
206
RRER AK
SRE RRR IY Ze EBON), Ze ETD
ARATE CA BRE, Holter Beate it Hit
FE BRI BOA, PAH Re te i — Fe Od PRE.
TIES BA, ALTE ARB BB AS EIS HE
PAL 2% ~49; BERRI I EE
13%; Fi SE ARTA A HH 17% 6
AFC eS RR
PRICE AY EA UAE HE A te YT], II
SUE OER ZIAISHE. RE
SARE AN AT SIVELY, PT EET IC] BC iE
EMER IS PT BETES BIAS FEY 22.
Me OY Fy BT HE A 3) 1~3 FF, CEA
ARIE AR, ALAS FRE Dy A AAA
ARMENIA ABS. A
HA PPR IC Sea Bh I FI, BE
TARA EE IT LR AB
FE GLE ITED «
DWE AE
LSE SEPA AE BRT APE AG TE AR
HA, EMT BE FUE: Ze APRA
Dh ASE FE BABE SAARC J BBE Be
A ERB ET He ULE. BEBE A
TERA PAA SHAG.
HUE AE
He AE: BAS Pe fe Yi J BF iJ
EB OULH ( 30_b He ab ah ttm 8 He at
HA). DH He. SEH TH HE. ME PT
SL AR He AAG Tt
IF MASERLF Tea PE ee BR Ae Ly DY ATE
ASR, CUT PARI. teat Le AY
FEA, HeLa FA Tt BE ee is He
TRIE EAE HE OE UR AP
SiC UL AB PE Ws Me BH DS} EA
FETE ATs TH LE ASA LG 20 BE). EF
ARAN F 359% BARA, SEG FF He
HAICD.
fer SP SCL TEE PF
fee SL Te BO AB AF LE
PRETEEN FETT. ae Rone Ay Be 1 BA PE BAL ft
fF, TELA EE BON OHARA, fF
PARA FAT RRP. TRAE TE
RARE. CE DRAB
URE FC TEATS AN Ly Fe BR EE
5% (Alternans Before Cardioverter Defibrillator
Trial, ABCD)", 320K EAT TTI HE
BT. IER, TURP TAT fe
FEE EK SS RR RAN —
PAC OIHE EAE, MS IR SEE KU
GE SAE.
a HEAR.
MRI AT Pi wR a PEE AL
SA ( ILS 20H ) FEAR SY AKU IS. ADE,
MRI FY FE CERES EL ALI 09 2 SE
TEE.
HARTI
FE Se Sue A a), I A
SORA ZIRE. PRR
RTT OMEN, 1 ML 2 AE, PAL ACS
FAS AE ME a SU te Ae.
FB ALA SUR IE Te Ae MIE MTA, FY PER
BIEBER. WME INTRER A,
PDR IS TF 2 eC fl EAP
EVRY A SCORER TRAE. EH AFR ioe AT
Ee AG fi Tt Sa A
PK MRT AOA INTE. LA
SCORER 1c AB AES, 7H I SR Be
MIB PEA RE RY
HEE RPE
Fi Brugada le HERI, MAT KE Brugada
2 Er TE BR A HO BR HEE 12K PA 10mee
kg, OSD Sh kif se. mY ECG TEA A A
—_—_—_—
BR
207ORES
RE
H, VAM BR) V2 BICRR) Vs PER AE AE
SEEN, LTH AORTA AT 2mm HF,
AA BATES. TEAS AEE aT
(AEH Ee He AAG (Ht QT TAL IOT RE), Fa
3 BU PRE FN HEB PSL RE YE
TITAN.
CHAK
22-2 HH T BBW, 22-1,
PA 22-2 7G TSMR. RA SC AL
ABE hi APE BETES) FE LE AE
HERI. TH AY AE ASAE, Hy BT PE EAR
i. AEE A PALA TT
UI UA AE ASE IE, LF HUT
NAL. WR SE Ae HM BR AE
WE), MP LATE.
R222 BRAVE
ASS Se Ae
Sea Mess
it OI
ask
CAFE BS A
+ Sea REA: AT LCF A
HLA ob LIE. TSH Se Pe BE LAR
HERG TE
> DNB FEL SEAR FIND
+ SNS
2 FESR HEPC DNAENER, BRIN ERE
AON
+ SIL RL ASAE « a IL a SE te
+ Holter Weill
EOL ete
+ MCU BODIE SR ERA RE TL
AMER ILR
+ RARER A
LEE
EL
DB AB NCAT PAF 22-1
FU 22-2). PRA ATE AT RES A RY
BW, (Lats a PAE Te Se He as IEEE
RABAT TEN TEN 5 Ly ALE SE A Me ewe
ABE.
AOAC LEA, EET eH DE
PRMEATTEIT et Pate PTE AS LAT Ll
BRA RETTIG, FRA IM EA Ha
ALR RTE 5
RI
FRAME 2 WEBB BF, HEAT AB FB oh
BEY, BRAD CREST . IX CLA Ae by EDN
HEAR NEE OS AT BEAR BL AE
EE MELE oh FPS PE CEES A
JEEPS Ma SUS WO ERE
BCL TF, EF Le Bh TENA FURIE HH
AG SES BEI AD, AG aEA TAB Be dE
BARE.
SES
ig 3 TE a RE A
Se, VL TARTS MR.
FEA BA ATES BPEL A EZ
MRR.
Sea
HEARS LRAT SEZ WT ED A Se
i. SPARE BS A HE aS,
FAG OM . WCAAT MDE 22 ENB
TAS A ARE ETE Ec ae AS A
HE. AEF ROR ENR, 48 “IME
en aby .
1A PRED eA LES, AT
AAAS AAR RRR ERICA aE.
IDA BADE 2B ERIE
PPR AEA E NIE RB A HA
ROALA PTA ICSE. HAL AA aie
SRNL 8 SUB) AER BLE
Wh AE. MATERA A EBT OL, HT,
208
REERR
22-1 DEH: 4 A IT EI
-[=} TERRE -{z} Ed
ar
RRS 209RES
Fa] 22-2 EDR: A REMIT
RA
Pease eta ete ee ee
Te ele hy py
cp ef le gi
FRERBENTOBRES. toes
EBS ATRIA AEST
PRA IEL
PRS RL
$0591. 238
Bite ae
AVM BALEAAL
SAR SENE GOES
PRs, TREK
Sere am
e
180:
135
90 te
eo
0
AUMA RRA. Ba
ER RE
1802
AUMARRES ME.
DRIER
Holter #3
ESR UP Gy He RB TE 8 atte Es aS: MAT AT
(RE: GATHMKA OSA, soe RM ew
210 ARRE BK
REST
—ARLATIMHT 8 Ao
ART fA
EAS WC AIR PS Af BEF, Ha FL SE
PETRA J) «RP AE fie PE HD AGS
WAFL. WIR AER. SRA
THUAE SA RD HE, A EAT EB TE IT
BAYA RR Rete. ABE
DE SEA TEENY, FF BARE A IN HE
We, BAP RSE ME, FE DE AEST.
PERE SCAG. AE RSS a EP EE mY AE BRS SETS
SR AYSA MAD IE AS INE TAFE TB
R.
BAH
Sheahan RG, Syncope and arthythmias: Role ofthe electro-
physiology study. Am / Med Sci 2001:322:37-43,
Sotenades £5, Evans JC, Larson MG, et al Incidence and
prognosis of syncope. N Engl Med 2002;347:878-885.
Wilde AM, Antzelevitch C, Borggrefe M, et al. Proposed
diagnostic criteria for the Brugada syndrome: Consensus
Report. Circulation 2002:106:2514-2519
(BR ae HF)
RRS
2118238
LRP
<2 UBRUEL SCD JR SLA RAS A a LO RGR. RA
SUE SCD 8] 494 30 77 ~45 7. SCD #594 B & Ab FH A231), BO% VAL BETES AER IE
SRAM AI GR Bs MAR he HAG ALLA AR AR, JE
RO JR 85 BY LAE 20S DAC AP HK ADS RS RAs a BRIE A SL) oS A EI
RARECEM, &
Hos MUIR IE MIDE 4] RATS EAR AH OL, 5 tp
RATES, LSA EH OMA 404 RM ICS PE HEF).
23-1 RA
+ LV RE SE
Brugada Siete
HQT ERATE ETE DEE
LEAS 3% (commotio cordis )
+ LV Dif MIEN, EPEAT
FEAR GES AO 2,
SEAR ALIK EAE
ERD IEE
LV Sf SAME
Late
CURE FFAS FA PH a 8)
BhelEL MI (HSE)
FRA
Je
SURE RA
HE FFE, Wolff-Parkinson-White {IE
DALE
HR
Chagas
CML
BA
FoR ME AL AEG 1H PUI E ah aE. Fh
AKANE Bbstein RAE. 6 HEA TE AHR
fi
CNET,
AMR tl
SP SCSCD (1) FB HE As LAK PF SB
212
BS Fe HE NE RCV), SU eB
(VF), SEC EF 23-1). BEE
HEED AR, Lo BEDR EF 75% 45 VFA, 20% jal»
REREAD SS, So 2256 TC MK A oh
BS ST RATE SLID A PI GC BAS
CVT), st Jes AT fie 7S FE tt ADE SE
HA FEE FEU SCD HA FIN FAS.
DLE
LAE FES LOC HE ER A RAS
DLA OL iti. Sh — PBL i AE i | VT
SEVP. ARAL AE Et LR PE AE
SPEEA WLR, (EY ARE GI Be aE
PED AR, 4% VITUS 2088). AEB
Fis, 60% SAE WIE AB Pr NTE La Bee FEL
MULE FES 1 S/T A, EASE SEE LR HY,
FPUE VE. BERARE INS EDAD
SULA ee ESA ee BERS. LS LAE AE
TEAM Gm, VIM RE ELE
3% ~39%, VF AY HAE HE I 4%~20% . IX BOE
Fe ATE OM EAT A. YB
By oh ABT BA AB AE 25 nN a A
ACME ST, Ate WIE 198 EA AR ET
EES YS RAR AAS (LV ) ABS
HEH. LAE ST BE Ly DLA EIR
RAR, ADEM TF SE IM A Rae
PELE (VTIVE ) B24 9 2.19%. FALL
ReAL BAL PEZE
#1 23-1 DBE
rR te
yi Ht BIE(SCD) BX H
SERRE at
RAMA SEE
Sea O AE
VE * rE
. ae qq Rae
DAE SSC MAIER LARS Lah
HR. BEV) RAED RMA VE) ROR
PFARERS
‘seu DAA SCD
VI)
AVI-VE ENB. eee SBR AF EAE RHE
VT BAD. SRE BIE HE MA 8 8
AEC ALIBTE
RKO E LVEF<35%
>
» » cae
GUST ORR eM amMAN B— Boo
DAB RDM sefEL ver,
AAWRARRMS RK VIM Ss
MCMER HAL S LER MOEA, ne
CAD oa RAE BOE NE CR Ae 78 I HS 80%
rey
213RAE PERE
VIAN VE AAA LYFE SR ( >60% ), JEYCAE
(RHE VE BY RAE ( 245% ), FEU HEA Bee VT
YAR (>30%). BEDWATAL, SACRE HE LAR I
6 BEE BSS UE FEAR AA, FES EE
BA VIVE 0% FCC OBI, PERE
WEATHER TI
FF EAR AD OK FA EAA YE ( GUSTO TEE), EH
RPE ST Be Hiei Ls WLR HE AY OFF.
DEFER A As EK BE RE, VT
3.5%, VF 394.0%, ATTA HY Hi 2.6%. fi
Bie WA TAL FEA Be 1 EET, 5
FEL FR HG BEE AH He, VT ATIVE
BEPC RE LR eA ES AOR
PERSE fs D4 Fe ML LAE J
48 NTA AeAE VT TE BEIM FET
Be
ein ELL
SCD SLI AY AB FE, MOR A LE ATE
FPSCHE VT eH, BUA Ac to 8 Oy A WLAER, MUR
F RABE TER A BL EMA. FELL
AD GEA HE 2G Yo XE He ALA SK BR BO BE BS
(AVID) 122 88, DA GAE VIVE 22 fe S24, 3
SEER ACY AT AEHEAS AVID BEDE AT
SAIS, SiN F 40% AAR, BEL SS
PHASE ICD 6 Fr EES WOE FT A Me PR aS
(WIEN). HRS Z5 Ta HAL, ICD I
FF ALAA DE TART AT PEER 39% , A OR
1%
EF (fi G9 ABH, AEA SEE VT the FT HAT
SCD (M208). Soi MAR A
Bi Bi BR AS OE FE SA FS EB A
(LVEF < 35%, 1ERRSEHE VT13~30 Bt) FLAS
OEM EAM VT, (HAS AESE IE), SAE RZG
SAY ALL, ALA ICD FT BR IIE TK 54%, &
PULSARS SE VT DAE BF SE TESS SPRAY
AR. DASE A GE TM PVT AEF ff
NF 40% 5 POTASH TS A
CARE HVT A EAT RL
91, BEZICD RAG WIATE. ICD AYIA BORE
PEGA ATT Be ER Ae PEER A
ob WEES 1 RM, LEP AR IE 22 A
DIRT WAS. Bon AS Aa
PR BAR DERE ie AR, ER FP 30% (FH)
23% ) fi) ABR-APHEL A ICD, YET 9B EAIRIS 39% »
FOV RAE PES.6%. Ac EDIE IRIN
FUG DIA TT LAK (MU AT PATE SE ): BAZ
PBIL HAE «LEP ES HRA A BOI
RAR ML SS TTA. Bed we UC bh Aa
MILI. OL RETA 9 SCD tA
“RPA IE RA, FEUER BLE. AVID OF
FAG T Mit 4 000% AR, BAT 16.9 + 11.5
PAA, SCD BRD" WY AY TE” AB PF 1 HE
17.8%.
APL HED LaG
SCD 78 HUE SEA TEAR ah ABELL
WEASEL AE. BABE AB eH SCD £9,
10%~15%. HHRMA. KFA
TAFT AT BSE ORE ETE AR LE
BEAR WS A OBE TSE 5 HANG Be 42 SCD INT TA.
MLE ASAS TA AT DOPE BI A, I LD
ABHE 1% ~25% NF. SCD AA BML HEL WL
RA AECL RRA, ERS OSE
Fi AF LEB 72% DA Ie. Be BCBOHE HE ty A
HRA AUR, ERE AEE VT AI BIE
TEVTIVE. 2IGHE VIVE 19 BAL AE
AT SARE. HU, FRB A BR
Ae RCE AE «A A HLA
BSAA WE. RRR
He, EEA RR ALA AL, Sh DHE LPR
HAS AT LAS IM AE VT HE, FEE
RA PIE A VT (WLS 20 9k ) JB HR SETI
SLR, AAR GREED URHIRME. RCT
SAME VT, 1 ES BE AT MBF HER BE HR”
KAY RR. SE ANTE SE BO SEAT I
LALLA BE LAP ANF 359% 1 AB A BAB
HLA ICD.
214
RRTERE
WC TRIE? TE BEAR AE AY FE
RAR BILE EF (ELM BE AIG, 229 Co PEE Ze
(NYHA) 4428 9 1 16, SB 09 90 REF ee
(9, ESC Set fi fei AME AIR( 4823-2). He
FEZ, PRE AI A BE A FE HE Fy RO
JRA, AUPE TABI, HOR HANES
FEO AR TE. CFF kui HE AM A A HE I
BY SEE AE SPT A AR, BEE SCD Le PRB
(50%0~80% )4& NYHA Il RAVE, (ATSE AS,
BEL SE S%~15%. NYHA V2 HET AK
Be AEE Ny He BIBER, BEBE CABS A a
HYPER ST “AERO”. FETA ARE EIT BE
BLT HL Ay FER SCA ES PEM.
R232 DR AMES NYA) PRSHARRE
BOF
NYHA SP HT SOE A Le
I 5%-18% 50%-80%
W 20%-50% 30-50%
WV 309%-70% —_$%-30%
KROME ARS
MEPL DLE
SLA SCD SEA: FeRAM ER HEE
SSH LARD UIG(HCM ). ik kA
TEE REE HEHE A, ZI FEL AG 500A
FEL ile TEOMA TT VA EBL A A LAY
SERA, BE 2 Be AS Ur 0 9b TP SSS
15 He BAS 62 Het). HOM Ae A 42 AE SCD A AY
SEI Is BENE: 1% ~4%, (ELIE I ES
BRE SCD fee AAA. BAS PS)
HCM £8.44 2&4: SCD HY fs POE « RB eH
FAK Holter tee til 2 SARE RE HE VT; A FAA ah
PRAT SL LV PSEC HEI HOM Ay Sete SCD HHL
Fi» 60% Be SCD fh HCM EE DAES
ICM AAA 114 TE 2 PE SR A
FPSEYE VT A277 LAE BE NSB TIE. SEP AE
RES HCM AL TMi Be, By
HOM J 45 fiz Bh WA 2A: SCD Hee He WL A AL
(123-2).
AT TEL— MEFER HERD, JESCD de:
GPE BA SDT. SEH ee SCD Fee HEARS
AY JEE NR BEE. Ebstein MATE. 3h KAY
7S Hes VBE. AC KH (AC. Eisenmenger
ERATE FER EA SNA. SLL SP
PUPRALE, SCD ASTER HEREIK, (LAN HEIN
Wi. ZR ARR IBE Tn a A RE Ag ICE
RTC IK, AE AE PES I RE. QTe a $5) HE He a
ST-THGE, HAR HAE SCD Fees.
SODA SUA
BOL PER AS UATE LI, FE Te
ABER ES IN, HF LF HAT TT AR EY SES
PR. BULA UATE WU RA, AE
FASC UL EET HE Be AF AEM BR AE EE
TED. Bie 22 ti Dk al AE 9
RE, Tem fA RD Fe aE. PETE, HK
HAIR 2P WLI PRK SCD HH TR, (ELLE REAR
HTL. RRL G98, BULA He MAT Ey
WL NIE AP EE
BOLE A SL WIE HE
WIE. BM SCD. FE HEBE AR SCD IN, Ly
FEL PAL AY ick Se) VF BR ee He Se
PE ROTA HEL fice sMRI. sy MRR Ae
LNA TRAE A LAL. SER
TERME REIN AAS, PA AG CEM
ALATA RA RB LSD Ae, a IE AY.
Wi es BY SAE FERED 95%, HELE 3 LI A
FREER BER ORTH R
TEAR SIRE
SEARS GE SE HS BATAAN 0.17%),
_ _
RA
215ETE
Fe 23-2 AL BRTESIE( SCD )
FRAME
ABR ELAL
HOM F036 3 ht 32/8) AES
aan gx see. eaEomie oe by
am
RAERERM
RRA
BFhaR 4
KQTRAE
PRERER
(renee)
ard §
KARE E
‘meh ihe ts
(ervell R24)
(Lange-Nielson &&4E)
Ge
Ratt
(BP. RM. HS)
Brugada arate
saa
BRERA
oe eee 6
SERB MMB DER AMAR)
KOTKATIVRATHNAARSE. AT ATCA
BiH RA ROT AMAL, RASTER NIT IAD
rt
HIRBE Re ~ Na"
Senansswey as 31
BEAL VE SHEET
216 RR&
E
#
a
{BAR ah A AWC IETS EAS
PEAS HIFR( 11.8%). eH SCD MBL AYRES
SEARS PEE IIE SE EAR Bh KOEI FF
ESA A MRT CH SHE it LAS we.
BEL AE IRIS 1 ETE FE Ae EAR LAR Aa ok
ARSE, FEM SHAK ALE SUK ZA). BACTETENT
ERAKR ARE BAP RRM, 59% V1
LADERA SE. EAR SAI SET GPE
SESCD A ADIEA TSM, HIF ABE
BART aa MA Bee. Be MA ER aH
TORRE PALE AS, CLA AR A RAY Ba AR RI
8 Fe Pike A hia MK aT Pap ee
JDK EE ES FA] REPEAL 1S 5 ASL aE
PA, MERE AEE BESS EMR AS
CHUA 1 FEAT SORE).
SULT IG L TERE
44E SCD af, “LILA” ry 5% ~109%,
HIP A ee Co ES TE EA a,
Sh TPA. BFF
BE EE DE BE HB AI SCD BY Be A
Hie QT SRF HECLQTS) 3248 QUe [AACE
440ms Ht 8 4¢( ULF 23-2). LOTS HZ
2247 000 Fi 10 000 A197 1 Pil, Hh LAE AS
SE. BEELIAT 3 000~4 000% LQI at
ZENG HE SER A HH Fe MY HE Bh LIM), BE
APR. ERE aT ia I LK
PMC ARN. 5 LOTS HAAN 5 >, Ha
FSS FANE SP iM, 3 SP ALTE 200 FC
5S 62.3%). LOTS Ht HF We 18K fH Jz Romano~
Ward 52> fiE C5 2 68, ie HE fe ); Beeb esi
Refi Jervell 5% Fy iE AM Lange-Nielson4i 44M
RO PREHEINE ) SILKE BAR. HAE
HE LQTS HHT PADRE ( 254) SESE A te
If )#9 LQTS (4823-3). 4S HRA Fe aL FE =
HG 25 OIF SLOTS 11) SPE J AS A A AGE
FRIESE.
Brugada Sp 2> fie. — Bh AS Ue 6 Ps GBA fe
Wi, FEA — WT SECSCD HB. BORA
£233 SHOTMMEKHER
+ HA RE AWE HE Ni HEH aE aE ACK
IEF Ee HFG A
ts ATL SLMS )
» CALIA5 Hy EAE ABE aT) ORM, RED OKE)
RET S25 ALAR hem. = a PU
SCAB. LORIE FAR FF)
+ TAMER BOE TEE, nL,
GOT aS AS. SIA Bibs A RI
JR)
+ Fah Trea Ose AA)
CHR Si ABP a «EB a A EA a)
+ ARAL AAS (SAUTE BRR SE
PEG SEL)
= CW
+ AA
+ PAE
FB ay oh A Ae MEA IEW. Brugada
RATE ME CREF 12 HK
Vin Vs SPUR SU Bete Heh, SF AiO BE A TCT
Jeu i WL ME ES) TBE), WLP 23-1. Brugada Sie
Prk RAFT LA BUIEADL VF BRI
VT. “Brugada” ft) Cos Pel 250 AY LAA BE Be
LT DA a Na HL TAR,
ARE DS eR Be PS eA
5 Pda PH YL ee
POUR FibBL, Hele SA. B
SARL) = HAST INEBZY ARAL —
ARSE. PAE AE
AS, Alte A BSG F Brugada 4 49 iE PF BS
4E SCD MSE ROPER AEE HP. FED HEM ag AY
2 SCD 829} fj AA Brugada sty sts 1 2E AY A
Fi, MWA SCD WY 4E SZ BEHEIK 6990. HH REWE A
Brugada 41H Fl 22 Bi) AB 48 AE 22 fe SCD BY
FEROTS 19%. AAEARAR AAG A
Be Brugada oly Ht FEL BE 6) FALL Nav” a8 BL
WERT 21H Brugada > NARS Hy AB (6,
Patti). FORA I ARA, Hue Ae et BU
ATM OHA. ICD SEM — AA TAIT Ir tk,
HEAP Lik JB, BINA SCD Bere BY
OO
MR
217TREE
Brugada Sn EAB M «
An BERR Hi BEE AE > DEFER HSE AE 1
‘Ps, OB Sat 8 RZ SCD, WAP HD PY Aa AS
Be OHA RS 5 SCORES HE A EE
ah PE i I ET
DEWERI). SUR 128 LE EET 09 ETE Se
7, 95% fH A> MERE Be ET Be PE HE. 107
PURPA TE SNP, 81% Hy ERE EH
Sa ey i AR AG Co TD, HR A A A
SEA AEE FAA SRB NER A
WLR HRA EIR). REP AEE
ABI 29.25%). WFR AEA A Be BA HE 3
PS UBC FE TR ERE IG. SEEM HP 76% 115
AAT LA SET, SC BR PF BE
HEN REHAB. APRA: 3 Sh ASP
CRP EA (38 Bil), AE FEEL 3%. TLR
ASRS EB 8 Woh AL EEE. Bip
AE HES SEP Be Af He J
Bia AER. Ze EAE CRP ( 487
HEAT A SIRS h RIN)
H23-4 LPR SH
ERR
Ate CMU
EP<35%
EP>35% {Hl <40%
PARMA A
Aisietk
HAAR
EPC35%
EF>35%
FEE
FsEAR HA
RISA
KOT AME
Fee
sere
Brugada te ff 1c>
Fete
eA PM
CABLE
Fea He CAE
BR, ACEL
BB. ACEI
ICD. BB, ACEI
BB. PM.ICD
META, ETT RAC ANE, #8 F BB. ICD, PM)
CHAK
TSW MES HRI. RR SRR
SEEN, (4K A: SCD MIRE IBLE
Fey BE HOOT A ALA HEH cE FEF SCD
RUE: SERRA 5 FAS BAD AN ABE = (.
AE BAe A BH PH)
SCORE OL HR 2G TAIT 7H TE
SEWN OTL AE). RL RE A
ARAYA, MEE RARE. MMU AT mH
Bore MEER Cy we PA HE AE ( 4 2H
YRC MU Hee BE) a LH.
25 HIE AE HES Ae). HAE AIST
HAE OME AE SH GE
BEAR HY Wak ON ERP HBL A AA 9 ed
BOE TSE et fh he Gea a
9). WU BAR. MRI AEA
Ket. AEP Ke te BET OR IAT
(4223-4).
ReV. BB. MMPI T7Zt HAN. ACEL
ReV, ICD, BB, ACEI
ReV, BB, ACEL, 524i ERPSREE VT Se EPS SR HENMLA ICD
ICD+BB. RFASE VT (A058 4] BBR)
BB. CCB. #358 HE ah
ICD, BB. aE
MEM TIMP BB ( 4054)
BB. ACEI.ICD.
a
218
RRAE PETE
BR
HSH RFA
BULA RRA OE ICD + {AHR + SHRP AR
FER AME PPA ICD
‘BeRIWPW Seer RFA
Ds ai. Pb a a
CES
ET EAT, TAGE BB. ACEI + ICD
FUE CME HI, ATER RAL A ICD
ACE: th TF HAR (CHULA BB: @ EARL MEAL DBR: ACH SBR: Wh AARC ETT: Re ak ACD: TAA HE
ESL - BRIDE PM: AGE REA: SEO) ATTA Re M3 at
SEB ANE:
SAU ME (2823-4). MPP AT EE
Co WLR MLB 2 HE > LEE BH, B SEAR BA
HS PEM Ga EARS. Wet HELL
Wii, EF ABNF 35% MBH. CEP
Bi minse ia, MAA ICD (WLS 12, 17, 20
FE). AL MUIR, EFA TF 35% (7h
F 40%, FAR RPSEPE VT BEYER, IEE
FEES HE. XY
HAICD.
BYTAIT IT RL RL ARM EAA ELBA,
ICD. BAER ANIA TEU — 2 DAT.
ACS Wa iti ALAR LE RIS ea
‘Hele. B SSAA ARE AL Ac aM ase 2E ME a.
24 o PERRET LS BER 5 HEE
LRTI
RPP IAL GWU, EF LDF 35% fy
RAIVAAICD. RRO TAIT DR.
SAREE AC TIB GE AE PEHEAT A eT
WR ARENA SE. PIRALOML
IH, EF(AKF 35% 198A 108 F ACEI AL B
SERDAAYH. PH TI A
SEE MAAE 7A 2A (WLS 25 HE), SE HB
SBA USAEALA ICD. 3 Sh— Se EN
HUA BAR IAIT. WPW £5 4 {iE 324: SCD 1
JE, HET SEE LN ; A
FE RAT HOM, BOL ARR HE AT EA LE
LQTS 8k Brugada 2x Fr fik (BH LALA ICD, 3
SBI HI — UE SF BARA EE LOTS f19 2549.
BAH IR, Zee VEIVT RH, 147 SCD
HNfEPR. AVALA ICD.
B SZ AA BA Bie RF SC Ey 1 Dy Ra
HE, AYP FE MM oss EN BI
Fa TES RESE «ly F] BE MAE SEE HEA EE
HOLT OIE DP, ERAN 40% (735
FY 28% ) AL FREE IB A B EPR
TAIT, FESCD RAMAN. BRUM
‘CBU FAL B SECA BA PAPAL AS Zo
LDL. — EAE TEP BBS, ALF EB
PRR, FUL UREFE TAY 22: BD 139%,
SAT BARAT, TRAIN. WML
BEPC EDR AGT Fe AVI SAC ty Ee
PRR AS ORE NTS SAT BAR, LUTE A
FA B AEP BEL Mi Ta il Me ak AB A] fe SCD Be A
WEAR 619%.
ART
A TOT FE Ey 1 PA SC 6,
BoD, a A ws eA A ti de,
SG TH Tie BER SCD BA A F109
HATH. MARR HLS SCD HK
OTA, CHR 2b FFE BR AE HE SPA AL CE
ryanodine ZENE, 47 ABHY 2, —2E AEE
FRM RR HE Ue Sa FE MR OAR AS, Be
‘eat ASE oS FE ETA
—_—_—_
RE
219REE
ARTA V 99625 ), (25 4e4= SCD Hes faiTA
KK. ATE NE C LAE AA
JS (CET. BSR AK Bt Na,K-ATP 1 A
PRU RA IB Le HR By ARF FG AT
BAHAR IL WL RH AVE SCD fH
FE We Sm, Td SS FS PR 5 ALS
BOREAS. MART BSE MS
FARR AaB tH — 3 OME, (RS OSE
HUTIDEHEROESE. AUEBESD AEA: SCD MATE
AR SHB IA EE SCD NTT IE BERL, HEAT
BUSA — AD GE 5 OA IS
AANA AR, BUBAIT iF ML AE PERI
SAGE PT FRAC E> SCD £9 EAE 5
BAR
‘AbKhatib SM, Granger CB, Huang Y, et al. Sustained ventric:
lar arthythmias among patients with acute coranary syr-
dromes with no SFsegment elevation: Incidence, predic-
tors, and outcomes. Circulation 2002;106:309-312,
‘Angelina P, Velasco JA, Flamm S. Coronary anomalies: Inck-
220
dence, pathophysiology, and clinical relevance. Crcula-
tion 2002;105:2449-2454.
Bardy G. Sudden Cardiac Death in the Heart Failure Trial
(SCD-HeFT). Late Breaking Clinical Tals, American Col-
lege of Cardiology 2004,
BoulitieF,Boisset |P, Connolly}, et al. Amiodarone interac-
tion with beta-blockers: Analysis of the merged EMIAT
(European Myocardial Infarct Amiodarone Trial) and
CAMIAT (Canacian Amiodarone Myocardial Infarction
‘ial databases. The EMIAT and CAMIAT Investigators
Gireulation 1999;99:2268-2275,
Drugs that cause torsades de pointes: htt//www.
‘atdrugs.org/medical-pros/drugliste/drugzlist htm,
Huikuri HV, Castellanos A, Myerburg R]. Sudden cardiac
death due to cardiac arthythmias. N Engl J Med
2001;345:1473-1482.
Maron 8}, Gohman TE, Kyle $B, Estes NAM, Link MS, Clini
‘cal profile and spectrum of commotio cordis. JAMA,
2002;287:1142-1146.
LUretsky BF, Sheahan RG. Primary prevention of sudden car-
diac death in heart failure: will the solution be shocking? |
‘Am Coll Cardiol 1997;30:1589-1597,
Vincent GM, Timothy K. Zhang L. Congenital long QT syn-
drome. Chin Electrophysiol Rev 2002;6:57-60.
Wilde AM, Antzelevitch C, Borggrefe M, et al. Proposed
agnostic criteria for the Brugada syndrome. Circulation
2002;106:2514-2519,
(BR aa iE)
RRS24g
Dei RIN IIT
GRR ASA FG HAA CRT RAR, URMERARKERRSA AH
HOFRESHSH, ERASE RSAARM RH, CEPA ROAE RYT K
FABRA LRA, HAMS AER BC ICD )89 IL, URI MT APE Es ah ad fe
CEMAE RY EER, RECA TAG, Baie A RARE HAR
HMARE, —FHRABLPARAM, F-AHAHLARM-LAGCEAPRHARS
BREEN BERFRAE, 2, CHEKFARKMRHMRERG REA AN BI FOS
BARR GHHELAA, CHEAPER, LALA EAMESE IST eT
DAE EEN SHER BH PRESEN HESS AER BET PIE A241).
R241 HARD
ee At ERAR
1A
#2 600~1 600mg qd Mit Me Be. deez
(GEOL 45.6164 1th) BLA ESC HE Ke OT IHL)
FA 2000-4 000mg qd( SHUCHRFH) FRASER: Bo AIH AE QTL),
RAMS
Pmt ie 150~450mg, 86 12 05h 1 2 SULLA FEF FR A) BODE aE GE QT
LD)
1Bx
Neha APY EITHD(LSmalky MALEE CNS R04 ARREST RENN ATE LT 22 fe)
2, S87 Angin AOUA BIE) ATRL ECS HE
SRV MELE) 150~300me 488 /) 81
1c
WRC 50~200me f 12) 1 I CNSR. CHE. BULA AEA
BP PAMACLAE) —150~300 mg 49.8 Mitt 1K PUBL. ER, CNS Ha BU FRSA AD
Te
8 SARAH URL AAMAS obo ayst2R. CNS WENA CSM) PED AE MeR
mas
MEA AT Je) 200-600mg ql ELE WEP REAG FEAR RHE FEA Be WCE
SHCA REY
Riki 80-240mg #12 ish 12K ESN. Det A AN Ss Ho a LE
WH
SOAR GLE G84) 240~360mg qd AE ALEE tL aE
ERM E>) 240~480mg qd ADIL AAR LEME AK HP
‘SE 0.125~0.35mg PO gd (SHI EOE SE BSA AD
watt DUAL PH RAE(6~18mg) i ET. OS POR A RE 10H)
Pepa Lng HERE RATE AT Lo A SLE
BAA 125~S00mg PO bid BOAR ATER OK Ta IE
‘oid — EL PRD CHL Ft 3 3-8 CNS: AR EE EB PO: Lg FO
yr
ERS
221PEER R Aw
RAMA
ZN RG BE El Pt
IBD FLAME RAL AR Ae BLL TE EE
REP ERA, A CAB S%. AL
HEA TEIT Le TH REE FN RTL
‘ill ps OE saa PO AST Fe
Sh, SAG SEE AS LI SI AST FR) 24-1).
SR AE DR Ia ls FH 18 SPE PE,
ATE RATA FA (24-2). HEIL AVAL
PARAS, A Ft aR Se SAY
SG ema Ah Per CN R25 BO
DSERAEIAIT SR. HID AE
BS aD ae BEA A EIS (a SE A
SEBEL I AcE aS ait aT i HE ROPE
i PME DBA) 9 12 SPB PA, Se
ISL if i) RAG SEO ETA JE ES ly
PR OSI. SEAR Hs Be FE aM ls BEN
WSR. LARGE ARLE, OPI Fe
BE Ak, ASP HE wi PDST AR AE.
AACR, IFT BHT
MUR AS RARE PASO
FEL VES OT Lh 25 9% Ph. HE
BI SAR I. BATE
FRB Be Ae iNT A a PT LAL
PAT TBE DERE BARA L CH.
Wi PRBEL SASH
AURA BCE LEEDS RG ZS AP REEAR HY Bod RR AE, Pe
TPE, (ARR LOL EZS YD, MT ANU A MELT.
Fa24-1 DEAE SF RBA BM
Atm
ENR BK me
cee fe
‘BRR SA) ahi BRAVE
RASA BB(AV)R(His)
Set
EARS BA
FR TE Hs
BP ERA
BR SER
222
RERIMEAR OB WaT
Fe) 24-2 2 bebe
Rashei ae
Pitot BRS
fTEPE: ae
RAR 223REDBARHAwIE
FE, PELL RA WW AME, WIR eB FE QRS
Uk, HORE ER AR HE, IEE
HUW. AIR FE AE QRS LBs EBLE, AS
FRET U, (LE SA eat A
AREA RIE— AE BCE SD A BMA
bah itit HVA, WALA ZL
fla AAT A: BEA / PR
BRET. AN REBT IED LPS Ca,
VARTA RR LD He TE PE, AS AL a A HE 9
BER. PRS BOAR AR PA
CTE. Aik, ASABE,
AE EAL MED CIS eH aL
HA, DBT ASB FEL 95 9 FS
wi
AVNRT. SANRTAIAT
8 Leal ah at PR Ie A UE
BACHE Ds [SA] Ai 3 [AV] 2 ) Oo AL
Fis EAR BEE I FE NT BHI
Bit) MPR ia OLE es EAE htt
(SVT) Ae a8 ST 3a AVNRT)
(7924-2). FEQRSI A bate, HSE
SUT iB Ly SHAS HR (SANRT) AS A He HE
AB LSE GX EARLE Fi EAA TE 1 fe, SSR
SWAG HY Ly BASLE), AEE 25 Mp BL IN Tr TAL
AULA 5 BAA Be aL HP SAP ER AE WT DL RS
AVNRT, SANRT AAT (F24-2). (HK, iil
‘A ip eA eS 9 BL 5
Save teenie
ss EZ Hid, HAS
» CEPR LEER ER
i WL ali ERE,
TERA B HEE T AM. ARB ERE
WSR La SEC AVR), EE He ARR
HEH) 30%. 9 ORS TAF
EESAVNRTIET EH. AAT Ff
5 SN LL CT ALF
SiS AAIE
SEE LAIN, 5 Re Seem He SOME Hla -L
2b), Hi BOT (LR 24-3). oO WL
BOR FRE PA Aa SH PPE SNELL I
Bh, Hel HA LIAR 8 Vk. Woll
White (WPW ) 4x 4 fiE AD LA AR tke
Bi 8 VaTM.
(124-3
wig
De TRIAS FEE Fe AND PD HEN,
RSA OTM LL. Hepes
PRA IE PT HEE Bean). 4 WPW ER AEA IE
Labi TT AE MO, AT
WPW Se Arf BEL, Fi EDR SOAR A, oy
TERETE NY fe OPES, MTA BLE.
FY, PRR ADL ASE, AEB
BH. 24 IL) QRS BE REE AN AY AAS
FSC a Ln, BEA AS WW ER AME SE
SLA AY TAREE. CSA AS AI FL
Site ES, TATE ee PE AE te.
AYP AR, TD IIE ARE ARE IE
FGM.
URS RAE HE, IAN Ay Di Pets ah RL ae
sO BD BINY, AT 2B BE QRS He Pe AT
AORN DRA. MST RG
—_—_S———
224
BRPLE EHS w IAT
90), ALVA I Se 8 LB BH 2.
— SE WPW Ha eh BAD LH HE
BALE (<10% ), BOW IPT ea LHR.
AOL Mane een te Be aL
east PERL ARR A, MELA HEM shit
BOE.
D5
BRANT ZETEL A 19:
Dba
SSAA Lo bad bah BA a OY at PE
FOL HLA Ethie Bl ( A244). EP)
TROL, BOE Ae tte PSE AR a Ah
BE, WLRGs Bt bah: DS HE AE QRS
BEL BM, RAW 150 KISH HAR
Beth ah 300% (4h, 2:1 FFE): QE QRS rah
P24
oma —
wee |
Fel 24-5
aaah
FL, RR AAS IU, EL a] SE fe HP
ABV BEAGLE MLA. LBS 1S0UE/
Spy, URGES, HT GCOS 2s ese EAT} A
TBE LA Ls FE AEP EY 3 1 REG).
Fi SEHD FE, AREAL PRB A, Ea: AE FE
SVE Ds 5 fe ick HEY ESE AS
Bh MPR DE ELE FR LAGI, QRS HE
ATLL.
setbbopitl
HERES 3 a RT ML
HORS, te Lb ete ohatia. ASE
30 Bb FE AE RE HED LE. Tk A AS
TBD PAI EE 8 Hats BE PL
24-5), QRS BOE A —, WREAK 5
TPES PEL ait (I) 24-6), QRSTGBAAS
- RAAB. — SP SE sea
ALAR, RE AEE RE, RIE HS, by A
ay Be th a
Ete
BSREWER E OB WRT
Fe 24-6
BUF. REREDATANTER AA, HS
LS 20 He.
SEMI
AYNRT, SANRTAIAT
HAE SVT BM, OH A HS
AY ATH, M0 Valsalva Sh (ERIE ME. tO
FREE UE WM, MRT IE BRAG IF ($8 25-1) 6H
BE WD Dk Be 4H Fo 8 AA EL 160 UC SPA FE
QRS BEF IFAT ESI ITAL PRES FL
Bl8mg). PPB ME bts ae
FARR TE DEATHS IL BY Ar TS 90% LAI
PE CRANK ES EADIE INL AT nt
PRA AFI BY BN a BL HA SE BF
ii NIFH Sree BAB
RIM ER, “ohata ERIE, TED
‘THOR, IN FAR PSE EAE QRS BESVT FIM, fu
OLA AFA, HT AR Ae. — EL
SR a i Dy A ek ATE A, 1M
TERN HES
BAMRALS BNF ORS We SVT — Boe
WD IT LY HiT RS FAB
WIEST. B SEORBLAPAL LAP ai Ltt
Ki BNE BITE NM. BH BE
SEL RIERA Hess bre Lah ANT P
FO AAT RR. RIE, & BM TK
TPT AUR A RA eee. Ee
DORADA te ite 24, SS B SER OTL
SAUDE Ps WOE FHL «AEA, REAR SE DEIN), RAE
PARES (ES FR). TART
ARE TRGB QRS BE SVT HZ A
FEAMEFAA A. Fit, FES BET MLS BR
Ant, ADAH RE PEA, (ELA ORC
FAITE TE A HES B SEBEL ALA
FAY = GBR AR ARE AS HD PRI A BE
BH, MRED AE SVT, FEILER FE IB
SST RAIE 2A RU Ia HK, AE AK
MEAT.
De tp aula RUBS
TE (a) Dra te ht AYA FT AVNRT
BRATION B ARAL HET HS TAA.
Att | CART ARRHA). DARSCIE AT
AOE ATIRTe k. 1eM B SEAR MEAAL IA
FETT ABER REAR Wb Sete (EN SN RET
Jeti.
Htiaee PAE
IAL Oy aie TR
FEAF Fs Jy PES HE U0) HE QRS
BL ATE ) SLE TAY, a F
Os
226
ORASPRELBAE HSM
ESR. ARTERY STA
BUG. eaPT MS ATE AY WR W 2550 fie
AUAVRT BEAR A>. GA AT ARAGON
FF, SRG CP IC RAR, TITS
AVNET ADL. BEL Fi 5 24 19 25 By & BH 108
FLARE FY. MULE AE 8 WE MY Ne RE Se le
KA. BOM FMEA TE
A Oe BEL 5 Fe A245 TAA TC
ALD) »
bbs
obo Sta Fe HEA BY IT Sols Be AL
(U1, LAB 25 HSH Ce HR SS GS HTT LL
GREG LAR Hi 2S EEE OE,
BRL TARA MELE. AHS
FPL GBH M2, EBS B ALARA
AUP FATA, TAA RHE ll a
Th ahT EBERT 48 /)sihf, MBE ZH Py EL
WEL ATEDETHER, fh HAE SH, TT
SREFH Sh RAE RTE SE Ah 4 J]. PN Re BL
APL SHE He BE CE ALA EE BOE 16, TT
FEAIDLES . MAB ALA EBRD Oy EL Bi
Shahi SKE.
FBS:
Fei CA A
iL FE SL
ESL Fea HW ta BEI
(BARES UNA LIB AR ) ASSES
FR. FEDERAL, Fr ani RRS ARI, Fa lok
EM. EL AC PK QT HI]. SBE
ASAE AR FADE, HE AS QT i), $85 INS STL
SEE LR AE NYP. AS EAS
ADSI UMAR TENA, HE BESE AP Bk
BU SR PE, CARR FT LA CEFF ao
SBT SHEAR A SS eA SL FE
HERE.
aethbohitt
AFB ALC EE, BTA
HAAS Be A, ZN AT VI Pe a See 2 ENT
AYR. PAT IQRS eb Bat we, WIR
RE AEE S SHE A WILE ML SE, BERS
PARRA PRATT. AH ES PE,
AAS ERATE SE ORS HeLa ae Ie
SEW DES LEM RD MBE.
FAA AA HORE QRS BEL BHTLIA, MALES
FAA. MAB TAA,
SE DNR AML, CREM. BR
5 TI Fe SIF FE QRS te aA, We
EBA SEO) 5 REBATE AAT HC
AREF, BED BAP AIR MLE. ELAR, Rae BF:
FEN BES, MURR A SIA, AT AS
PARA PRET. CE AMON Ae, ALE EH SL ML
BAP ANG IE. 5 LED RI He.
SPREE R A, TORR ZA
TTA BRB LA ID AIT. 50% LE
PAR HEL ARE RELA RB ME BAIA A THERE
SEROMA OATT «EPRI AE
SS 1S PE LA a AR He PB
WARE BO UR. RH SB, HEPA HEE
FETE, ALLA RE RHE ICD HLA. ICD
A Sit SBS FR SAF HAS a A
‘@Al( #5 A 200mg).
D> BURA LERLA ICD Ji 24 i, BD
SETA AHL" RR” 5 SUE MTSE TA
DAR Be Bas P(E A he BH
AWA AE), TART AG YE 9 LP BE ke
RR, AGH ML HAMA. Bw, ICD
Sit ECHEC EL, PA BERR HK B SEBEL
HOTA Feta CMe SH CH AH th,
CURIRAI AL B SZABO.
ARAB
BEE SE PURITY, LAR HR
TRE PGTT OLD Soa. ate
SEVEN LIA ORAM
FELTED AA HIRE, BSS MLHE TA
AUG RFD AOR.
DBA
227RELDBARHAwIE
AP ABSP ARR MY AES AIT I BS
ARSE FAP 28 1 8 EHEC A De HOR EH: Bt
AB AUAE Hy Ly DEH Js D5 Eb BH 8) PREG By FE
BPE T PARE. A TATA
FEAF ERG OLRM BE, MET
ARICA 2S MEAT ED TIT FA. Bll
HPT AEA HY AN EI HET HE
BRT DAK HAD.
BAIR
Gredner SC, Klingenheben T, Mauss O, et al. Electrical storm
in patients with transvenous implantable cardioverter.
defibrillators: Incidence, management and prognostic
implications. j Am Coll Cardiol 1998;32:1909-1915,
Epstein AE, Ellenbogen KA, Kirk KA, etal Clinical character
istics and outcome of patients with high defbellation
thresholds. Circulation 1992;86:1206-1216,
Ganz U, Friedman PL, Supraveniricular tachycardia. Engl |
Med 1995;332:162-173.
Jackman WM, Beakman KJ, McClelland |H, et al. Treatment
of supraventricular tachycardia due to atrioventricular
nodal reentry by radiofrequency catheter ablation of slow
pathway. N Engl | Med 1992:327:313-318.
‘Masood A. Clinical spectrum of ventricular tachycardia. Cir
‘ulation 1990;82:1561~1572,
Members of the Sian Gambit, New approaches to antiar-
rhythmic therapy: I. Emerging therapeutic applications of
the cell biology of cardiac arrhythmias. Circulation
2001;104:2865-2873.
Prystowsky EN. Diagnosis and management of the preexc
tation syndromes. Curr Probl Cardiol 1988;13:225-310,
‘Saksena S, PoczobuttJohanos M, Castle LW, etal. Long-term
multicenter experience with a second-generation
implantable pacemaker-defibilator in patients with
‘malignant ventricular tachyarrhythmias. Am Coll Cardiol
1992;19:490-499,
(Pk te HE)
RAEBR
#2 LPEATSE PED RTE SS ak
BEE AIAN RECA Di Hh HL AE T AAG IF as had oR Oy me, 1986 RECA
AMAR ERA CEST ARERBE LBC HP PRRS RS HMA VIBE. EC
FART AA EA EE EMR AEA BH WPW ROME SEER, RECA BDI IE
SRD SHRE
ASH fie RECA Ge BEE SA) — 4 fa 2 BE
SL BOLE ET FE EA Bt BR”
HEAL TIE HAG SF RB A IA (25-1). &
FE BEY OL te Ti, SE
(*HRLER” ), SBCA AL 1
fe 3H
BEATA (CRE AUER” ), MAE et I RB a)
ARTA AS ALI)» SULTS ay BEI
SAS EI NUE Te AS GS TE fe
HAG CFE FUR, LK 5 AY Td He), (ELS BT
TENA SPAR, (EL SE BHA * Ph Hh A” FECL
25-1). PEDAL fee SF Hs UG IL AL, BE
AE AG SE EAS oh a AL Te A BE Fe
3H Pe, REE TMB oN” TIE.
RECA (8 FP EAST OR”, (LB
TEA fe aU
SHH RARER
$f 380TH ARR) fe THLE 300-1 000K Hz AY
SETA 2 ET BTA Mk). BP Ae Ba
As, 14824 5~Omm, PRELS 2-3mm. si AF RF
ARE Ae oh AS TH SP AE i PR BH
FRA ARMA EAD. ol BERR ih
RE AZ TEAK BH IK (0 A Be. HED AL
De ABE EAR ah HK ML The HEE BEAT THB RECA “Pd
HEM MATA KEM BL. EHF RECA BY RAE
1, SAE AE BR, At, RECA Ae
ME ( $8 25-1).
25-1
SERA IT LRA HE AAD MAE ( %) TRE
AVNRT. 95+ TBM <1%)
WRW S560 fiE 85-95(4710),95+ (Jef) DF EBELH, EARN MRTALAE, aL ELE
AVI TPH 98-100 FORM)
“Rha 85-95 FAVE Fe Eb a) ASB PW)
50-60( AE MA. path)
804 #71 965 A) WS CERES ALAM)
60-70 WTP BAE (2% ~4%), WE SE
CADALREIVT 64-81 MILTLA, SKF RAE
RLM VT 95+ eo (FL)
PRE VT 85-100 Jia
AB, 4: 38003 :A VNR, 12554 SB HE Cah AAV, BER SAV, BUSI ACAD, REARS DRO ML SHEE TIA, LYE
(eat. ef, ae a WPW, Wolf Parkinson-White
—_——o
RARE
229BS HEMB EMA BS SS SIIE me
(125-1 8 FA aL i he ae PEE De GIES GY Be BL
ALO PARAM
Ra
“ERGS”
(Ste IB)
“ansense”
(eB. ERRORS
BR) MANES T ARI
mHeS
eer
(RFCA)
RECA 48 JF 2 HE
Bae SaaS RSNA”
‘Hebi ae. Hh ah
“GHGs” oT
6S. ES CSE
TAB GB
fer 4m
SPAM REO mea
(50st
aE $e BU 85 AVNAT 1B FA BR AS BB
Bite RAE
hfe Fike
‘fe F a
CMfeafadh.
sane
230 RRSLEMSEORARNSS SH
RB2ERREOHUE
Fi8 3 ATA HE Ls Bh (AVNET) Je Be
i TAS ERE Pet att a, 29 47 60%.
AVNRT 24s fF tit i Heats DEIR, AY Be A PAE
PERE. SARORS Lait, WANE,
160~250 UK / 5h. AVNRT fil 22 A BL i JE BE
HARA RNS AG Sa BS, “MOR”
ES BA, EWE EER). AVNRTS HB
FRR RI AS, HAE Bi 18 : IE MRE AVNRT 5,
IESE. BE ALF Koch = A Riis
Koch [fH SS, Todaro RELI REF
DKSE OI AUR( PA 25-2). HARM EIHEA stiE
FEAR KEE (Koch = fA AS FG BBSP ), BE
Ai F Koch = $0 HHL: BX 4k, LRH AVNRT
SUDA RECA HAGA. CET RE A, LY
PA AA BG TEE fe SP BY FESO, FH
RAK TOMER. REG
BEE Pe APL ALLY bill ( FR) 25-2, F ), ee
SEAR HE BK BE (a fed) OAS